EXIDE TECHNOLOGIES
The
information in this preliminary prospectus supplement and the
accompanying prospectus is not complete and may be changed. This
preliminary prospectus supplement and the accompanying
prospectus are part of an effective registration statement filed
with the Securities and Exchange Commission. This preliminary
prospectus supplement and the accompanying prospectus are not an
offer to sell these securities, and we are not soliciting offers
to buy these securities in any jurisdiction where the offer or
sale is not permitted.
|
Filed pursuant to Rule 424(b)(5)
Registration No. 333-141725
Subject
to Completion, Dated August 28, 2007
Preliminary
Prospectus Supplement to Prospectus dated April 13,
2007
Subscription
Rights to Purchase up to 14,000,000 Shares
of Common Stock at $6.55 per Full Share
We are distributing, at no charge, to holders of our common
stock non-transferable subscription rights to purchase up to
14,000,000 shares of our common stock. You will receive one
subscription right for each share of common stock owned at
5:00 p.m., New York City time, on August 30, 2007.
Each subscription right will entitle you to purchase
0.22851 shares of our common stock at a subscription price
of $6.55 per full share, which we refer to as the basic
subscription privilege. The per share price was determined by
our board of directors after negotiations with the parties to
the standby purchase agreement described below and after a
review of recent historical trading prices of our common stock
and the closing sales price of our common stock on
August 27, 2007. If you fully exercise your basic
subscription privilege and other stockholders do not fully
exercise their basic subscription privileges, you will be
entitled to exercise an over-subscription privilege to purchase
a portion of the unsubscribed shares of our common stock at the
same subscription price of $6.55 per full share. To the extent
you properly exercise your over-subscription privilege for an
amount of shares that exceeds the number of the unsubscribed
shares available to you, any excess subscription payments
received by the subscription agent will be returned, without
interest, as soon as practicable.
The subscription rights will expire if they are not exercised by
5:00 p.m., New York City time, on September 28, 2007,
unless we extend the rights offering period. If any subscription
rights (including any over-subscriptions) remain unexercised
after the expiration of the rights offering, two of our existing
stockholders will be deemed to have exercised those subscription
rights immediately prior to the expiration of the rights
offering and, subject to certain conditions, will purchase at
the subscription price of $6.55 per full share the shares
of our common stock issuable upon the exercise of those
subscription rights that were not exercised by our other
stockholders, pursuant to a standby purchase agreement entered
into among these stockholders and us.
You should carefully consider whether to exercise your
subscription rights prior to the expiration of the rights
offering. All exercises of subscription rights are irrevocable.
Our board of directors is making no recommendation regarding
your exercise of the subscription rights. The subscription
rights may not be sold, transferred or assigned and will not be
listed for trading on The NASDAQ Global Market or any stock
exchange or market or on the OTC Bulletin Board.
Our board of directors may cancel the rights offering at any
time prior to the expiration of the rights offering for any
reason. In the event the rights offering is cancelled, all
subscription payments received by the subscription agent will be
returned, without interest, as soon as practicable.
The shares of common stock are being offered directly by us
without the services of an underwriter or selling agent.
Shares of our common stock are traded on The NASDAQ Global
Market under the symbol XIDE. On August 27,
2007, the closing sales price for our common stock was $7.02 per
share. The shares of common stock issued in the rights offering
will also be listed on The NASDAQ Global Market under the same
symbol.
The exercise of your
subscription rights for shares of our common stock involves
risks. See Risk Factors beginning on
page S-6
of this prospectus supplement, page 2 of the accompanying
prospectus and the documents incorporated by reference herein to
read about important factors you should consider before
exercising your subscription rights.
Neither the Securities and Exchange Commission nor any state
securities commission has approved or disapproved of these
securities or passed upon the adequacy or accuracy of this
prospectus supplement or the accompanying prospectus. Any
representation to the contrary is a criminal offense.
Prospectus
Supplement dated August , 2007
As permitted under the rules of the Securities and Exchange
Commission, or the SEC, this prospectus supplement and the
accompanying prospectus incorporate important business
information about Exide Technologies that is contained in
documents that we file with the SEC, but that are not included
in or delivered with this prospectus supplement and the
accompanying prospectus. You may obtain copies of these
documents, without charge, from the website maintained by the
SEC at www.sec.gov, as well as other sources. See Where
You Can Find Additional Information in the accompanying
prospectus.
You should rely only on the information contained in or
incorporated by reference into this prospectus supplement and
the accompanying prospectus. If the description of the offering
varies between this prospectus supplement and the accompanying
prospectus, you should rely on the information in this
prospectus supplement. We have not authorized anyone to provide
you with different information from that contained in or
incorporated by reference into this prospectus supplement or the
accompanying prospectus. You should assume that the information
contained in or incorporated by reference into this prospectus
supplement and the accompanying prospectus is accurate only as
of any date on the front cover of this prospectus supplement,
the accompanying prospectus or the date of the document
incorporated by reference, as applicable, regardless of the time
of delivery of this prospectus supplement or the accompany
prospectus or any exercise of the subscription rights. Our
business, financial condition, results of operations and
prospects may have changed since those dates. We are not making
an offer of these securities in any state where the offer is not
permitted.
TABLE OF
CONTENTS
Prospectus
Supplement
|
|
|
|
|
|
|
Page
|
|
|
|
|
iii
|
|
|
|
|
S-1
|
|
|
|
|
S-6
|
|
|
|
|
S-10
|
|
|
|
|
S-11
|
|
|
|
|
S-12
|
|
|
|
|
S-25
|
|
|
|
|
S-29
|
|
|
|
|
S-29
|
|
|
|
|
S-29
|
|
|
|
|
S-30
|
|
|
|
|
S-30
|
|
|
|
|
S-30
|
|
i
Prospectus
|
|
|
|
|
|
|
|
1
|
|
|
|
|
2
|
|
|
|
|
2
|
|
|
|
|
3
|
|
|
|
|
3
|
|
|
|
|
4
|
|
|
|
|
6
|
|
|
|
|
7
|
|
|
|
|
8
|
|
|
|
|
9
|
|
|
|
|
9
|
|
|
|
|
10
|
|
|
|
|
10
|
|
|
|
|
19
|
|
|
|
|
23
|
|
|
|
|
23
|
|
|
|
|
23
|
|
|
|
|
24
|
|
ii
QUESTIONS
AND ANSWERS RELATING TO THE RIGHTS OFFERING
What is
the rights offering?
We are distributing, at no charge, to holders of our common
stock non-transferable subscription rights to purchase shares of
our common stock. You will receive one subscription right for
each share of common stock you owned as of 5:00 p.m., New
York City time, on August 30, 2007, the record date. The
subscription rights will be evidenced by rights certificates.
Each subscription right will entitle the holder to a basic
subscription privilege and an over-subscription privilege.
What is
the basic subscription privilege?
The basic subscription privilege of each subscription right
gives our stockholders the opportunity to purchase
0.22851 shares of our common stock at a subscription price
of $6.55 per full share. We have granted to you, as a
stockholder of record as of 5:00 p.m., New York City time,
on the record date, one subscription right for each share of our
common stock you owned at that time. For example, if you owned
100 shares of our common stock as of 5:00 p.m., New
York City time, on the record date, you would receive 100
subscription rights and would have the right to purchase
22.851 shares of common stock (rounded down to
22 shares, with the total subscription payment being
adjusted accordingly, as discussed below) for $6.55 per full
share with your basic subscription privilege. You may exercise
the basic subscription privilege of any number of your
subscription rights, or you may choose not to exercise any
subscription rights.
If you hold your shares in the name of a broker, custodian bank,
dealer or other nominee who uses the services of the Depository
Trust Company, or DTC, DTC will issue one subscription
right to the nominee for each share of our common stock you own
at the record date. The basic subscription privilege of each
subscription right can then be used to purchase
0.22851 shares of common stock for $6.55 per full share. As
in the example above, if you owned 100 shares of our common
stock on the record date, you would receive 100 subscription
rights and would have the right to purchase 22.851 shares
of common stock (rounded down to 22 shares, with the total
subscription payment being adjusted accordingly, as discussed
below) for $6.55 per full share with your basic subscription
privilege.
Fractional shares of our common stock resulting from the
exercise of the basic subscription privilege will be eliminated
by rounding down to the nearest whole share, with the total
subscription payment being adjusted accordingly. Any excess
subscription payments received by the subscription agent will be
returned, without interest, as soon as practicable.
What is
the over-subscription privilege?
In the event that you purchase all of the shares of common stock
available to you pursuant to your basic subscription privilege,
you may also choose to purchase a portion of any shares of our
common stock that are not purchased by our stockholders through
the exercise of their basic subscription privileges. The maximum
number of shares of our common stock that could be purchased by
you pursuant to your over-subscription privilege will be
determined according to the following formula based in part on
your percentage ownership of our outstanding common stock as of
5:00 p.m., New York City time, on the record date: (total
number of unsubscribed shares multiplied by your
ownership percentage of our outstanding common stock at the
record date divided by two). For example, if you owned 2%
of our outstanding common stock on the record date and you
properly exercised your basic subscription privilege in full,
you may purchase up to 1% of the unsubscribed shares with your
over-subscription privilege.
In order to properly exercise your over-subscription privilege,
you must deliver the subscription payment related to your
over-subscription privilege prior to the expiration of the
rights offering. Because we will not know the total number of
unsubscribed shares prior to the expiration of the rights
offering, if you wish to maximize the number of shares you
purchase pursuant to your over-subscription privilege, you will
need to deliver payment in an amount equal to the aggregate
subscription price for the maximum number of shares of our
common stock available to you, assuming that no stockholder
other than you and the standby purchasers (who have agreed to
exercise their basic subscription privileges in full) has
purchased any shares of our
iii
common stock pursuant to their basic subscription privilege. See
The Rights Offering The Subscription
Rights Over-Subscription Privilege.
Fractional shares of our common stock resulting from the
exercise of the over-subscription privilege will be eliminated
by rounding down to the nearest whole share, with the total
subscription payment being adjusted accordingly. Any excess
subscription payments received by the subscription agent will be
returned, without interest, as soon as practicable.
What is
the role of the standby purchasers in this offering?
In connection with the rights offering, we have entered into a
standby purchase agreement with Tontine Capital Partners, L.P.
or, together with its affiliates, Tontine, and Legg Mason
Investments Trust, Inc., or Legg Mason, which we refer to
collectively as the standby purchasers. Subject to certain
conditions, the standby purchase agreement obligates us to sell,
and requires the standby purchasers to purchase from us, all of
the shares purchasable with their basic subscription privileges.
Each of the standby purchasers has agreed not to exercise its
over-subscription privilege in any amount. In addition, the
standby purchase agreement obligates us to sell, and requires
the standby purchasers to purchase from us, any and all shares
of our common stock issuable upon the deemed exercise by the
standby purchasers immediately prior to the expiration of the
rights offering of any subscription rights that were not
exercised by other stockholders prior to the expiration of the
rights offering. The price per full share paid by the standby
purchasers for such common stock will be equal to the
subscription price paid by our stockholders in the rights
offering.
Under the terms of the standby purchase agreement, the standby
purchasers have agreed to a maximum ownership limitation,
referred to in this prospectus as the contractual 49.9%
ownership limitation, that restricts them from owning in the
aggregate shares of our common stock on the closing date of the
transactions contemplated by the standby purchase agreement in
an amount that exceeds 49.9% of the total outstanding shares of
our common stock on that date. As a result, if no other
stockholders exercise their subscription rights, based on the
amount of our outstanding common stock owned in the aggregate by
the standby purchasers as of August 28, 2007, this
contractual 49.9% ownership limitation would limit the amount of
common stock that would be issued to the standby purchasers
pursuant to the standby purchase agreement. Under the standby
purchase agreement, two-thirds of the unsubscribed shares will
be allocated to Tontine and one-third of the unsubscribed shares
will be allocated to Legg Mason. See The Rights
Offering Standby Commitments and Plan of
Distribution.
Why are
we conducting the rights offering?
We are conducting the rights offering to raise capital that we
intend to use to provide additional liquidity for working
capital, capital expenditures, strategic opportunities,
additional restructuring and general corporate purposes. We
believe that the rights offering will strengthen our financial
condition by generating additional cash and increasing our
stockholders equity.
How was
the $6.55 per full share subscription price
determined?
Our board of directors determined the terms of the right
offering and the standby purchase agreement after negotiations
among the parties to the standby purchase agreement. In
determining the subscription price, our board of directors
considered a number of factors, including: the likely cost of
capital from other sources, the price at which our stockholders
might be willing to participate in the rights offering,
historical and current trading prices for our common stock, our
need for liquidity and capital and the desire to provide an
opportunity to our stockholders to participate in the rights
offering on a pro rata basis. In conjunction with its review of
these factors, our board of directors also reviewed a range of
discounts to market value represented by the subscription prices
in various prior rights offerings of public companies. The
subscription price was established at a price of $6.55 per full
share. The subscription price is not necessarily related to our
book value, net worth or any other established criteria of value
and may or may not be considered the fair value of our common
stock to be offered in the rights offering.
iv
Am I
required to exercise all of the subscription rights I receive in
the rights offering?
No. You may exercise any number of your subscription rights, or
you may choose not to exercise any subscription rights. However,
if you choose not to exercise your subscription rights in full,
the relative percentage of our common stock that you own will
decrease, and your voting and other rights will be diluted. In
addition, if you do not exercise your basic subscription
privilege in full, you will not be entitled to participate in
the over-subscription privilege.
How soon
must I act to exercise my subscription rights?
The subscription rights may be exercised at any time beginning
on the date of this prospectus supplement and prior to the
expiration of the rights offering, which is September 28,
2007, at 5:00 p.m., New York City time. If you elect to
exercise any rights, the subscription agent must actually
receive all required documents and payments from you prior to
the expiration of the rights offering. Although we have the
option of extending the expiration of the rights offering, we
currently do not intend to do so.
May I
transfer my subscription rights?
No. You may not sell or transfer your subscription rights to
anyone.
Are we
requiring a minimum subscription to complete the rights
offering?
No.
Can our
board of directors extend, cancel or amend the rights
offering?
Yes. We have the option, with the approval of the standby
purchasers, to extend the rights offering and the period for
exercising your subscription rights for a period not to exceed
15 days, although we do not presently intend to do so. Our
board of directors may cancel the rights offering at any time
prior to the expiration of the rights offering for any reason.
In the event that the rights offering is cancelled, all
subscription payments received by the subscription agent will be
returned, without interest, as soon as practicable. We also
reserve the right to amend or modify the terms of the rights
offering.
Has our
board of directors made a recommendation to our stockholders
regarding the rights offering?
Our board of directors is making no recommendation regarding
your exercise of the subscription rights. Stockholders who
exercise subscription rights risk investment loss on new money
invested. We cannot assure you that the market price for our
common stock will be above the subscription price or that anyone
purchasing shares at the subscription price will be able to sell
those shares in the future at the same price or a higher price.
You are urged to make your decision based on your own assessment
of our business and the rights offering. Please see Risk
Factors for a discussion of some of the risks involved in
investing in our common stock.
What will
happen if I choose not to exercise my subscription
rights?
If you do not exercise any subscription rights, the number of
shares of our common stock you own will not change; however, due
to the fact that shares will be purchased by other stockholders
in the rights offering, including the shares purchased by the
standby purchasers pursuant to their obligations under the
standby purchase agreement to purchase any shares not subscribed
for in the rights offering, your percentage ownership after the
completion of the rights offering and the closing of the
transactions contemplated by the standby purchase agreement will
be diluted. In addition, in connection with the rights offering,
we will be required to make downward anti-dilution adjustments
to the conversion price for our outstanding convertible notes
and exercise price for our outstanding warrants. Accordingly,
you may also be subject to increased dilution from the
conversion of convertible notes or exercise of warrants to the
extent the noteholders or warrant holders convert or exercise
these securities.
v
How do I
exercise my subscription rights? What forms and payment are
required to purchase the shares of our common stock?
If you wish to participate in the rights offering, you must take
the following steps:
|
|
|
|
|
deliver payment to the subscription agent using the methods
outlined in this prospectus supplement before 5:00 p.m., New
York City time, on September 28, 2007; and
|
|
|
|
deliver a properly completed rights certificate to the
subscription agent before 5:00 p.m., New York City time, on
September 28, 2007.
|
If you cannot deliver your rights certificate to the
subscription agent prior to the expiration of the rights
offering, you may follow the guaranteed delivery procedures
described under The Rights Offering Guaranteed
Delivery Procedures.
If you send a payment that is insufficient to purchase the
number of shares you requested, or if the number of shares you
requested is not specified in the forms, the payment received
will be applied to exercise your subscription rights to the full
extent possible based on the amount of the payment received,
subject to the elimination of fractional shares.
When will
I receive my new shares?
If you purchase shares of our common stock through the rights
offering, you will receive your new shares as soon as
practicable after the closing of the rights offering. Subject to
state securities laws and regulations, we have the discretion to
delay allocation and distribution of any shares you may elect to
purchase by exercise of your subscription rights in order to
comply with state securities laws.
After I
send in my payment and rights certificate, may I cancel my
exercise of subscription rights?
No. All exercises of subscription rights are irrevocable, even
if you later learn information that you consider to be
unfavorable to the exercise of your subscription rights. You
should not exercise your subscription rights unless you are
certain that you wish to purchase additional shares of our
common stock at a subscription price of $6.55 per full share.
What
should I do if I want to participate in the rights offering, but
my shares are held in the name of my broker, dealer, custodian
bank or other nominee?
If you hold your shares of our common stock in the name of a
broker, dealer, custodian bank or other nominee, then your
broker, dealer, custodian bank or other nominee is the record
holder of the shares you own. The record holder must exercise
the subscription rights on your behalf for the shares of our
common stock you wish to purchase.
If you wish to participate in the rights offering and purchase
shares of our common stock, please promptly contact the record
holder of your shares. We will ask your broker, dealer,
custodian bank or other nominee to notify you of the rights
offering. You should complete and return to your record holder
the form entitled Beneficial Owner Election Form.
You should receive this form from your record holder with the
other rights offering materials.
Are the
standby purchasers receiving any compensation for the standby
commitments?
No. The standby purchasers are not receiving any compensation
for the standby commitments.
Are there
any conditions to the standby commitments?
Yes. The obligation of the standby purchasers to fulfill the
standby commitments will be subject to a number of conditions.
Please see The Rights Offering Standby
Commitments.
vi
How many
shares will the standby purchasers own after the
offering?
As of August 28, 2007, Tontine and Legg Mason owned
17,183,870 and 8,452,431 shares, or 28.0% and 13.8%, of our
outstanding common stock, respectively. As a result of the
contractual 49.9% ownership limitation applicable to the standby
purchasers, if no stockholders other than the standby purchasers
exercise their subscription rights, the standby purchasers
together would be required to purchase a maximum of
approximately 9,851,475 shares of our common stock (instead
of the full 14,000,000 shares offered hereby), of which
approximately 6,567,650 and 3,283,825 shares of our common
stock would be allocated to Tontine and Legg Mason,
respectively. Accordingly, the aggregate beneficial ownership of
the standby purchasers in our outstanding common stock would be
approximately 35,487,776 shares, or 49.9%, of our
outstanding common stock on the date of the closing of the
transactions contemplated by the standby purchase agreement.
How many
shares of our common stock will be outstanding after the rights
offering?
As of August 28, 2007, we had 61,266,314 shares of our
common stock issued and outstanding. We expect to issue
14,000,000 shares of our common stock in this rights
offering through the exercise of subscription rights and the
transactions contemplated by the standby purchase agreement.
After the rights offering and the closing of the transactions
contemplated by the standby purchase agreement, we anticipate
that we will have approximately 75,266,314 shares of our
common stock outstanding. As a result of the contractual 49.9%
ownership limitation applicable to the standby purchasers, if no
stockholders other than the standby purchasers exercise their
subscription rights, we will issue only 9,851,475 shares of
our common stock (instead of the full 14,000,000 shares
offered hereby) and will have approximately
71,117,789 shares of our common stock outstanding.
How much
money will the Company receive from the rights
offering?
Assuming the contractual 49.9% ownership limitation applicable
to the standby purchasers is not reached, we expect the gross
proceeds from the rights offering and the transactions
contemplated by the standby purchase agreement to be
approximately $91.7 million. While we are offering shares
in the rights offering with no minimum purchase requirement, the
standby purchasers have agreed, subject to certain conditions
and the contractual 49.9% ownership limitation applicable to the
standby purchasers, to exercise their basic subscription
privileges in full, to waive their over-subscription privileges
and to purchase at the subscription price of $6.55 per full
share any and all shares of our common stock issuable upon the
deemed exercise the standby purchasers immediately prior to the
expiration of the rights offering of any subscription rights
that were not exercised by other stockholders prior to the
expiration of the rights offering. As a result of the
contractual 49.9% ownership limitation applicable to the standby
purchasers, if no stockholders other than the standby purchasers
exercise their subscription rights, we would expect to receive
gross proceeds from the rights offering and the transactions
contemplated by the standby purchase agreement of approximately
$64.5 million. Please see Use of Proceeds and
The Rights Offering Standby Commitments.
Are there
risks in exercising my subscription rights?
Yes. The exercise of your subscription rights involves risks.
Exercising your subscription rights involves the purchase of
additional shares of our common stock and should be considered
as carefully as you would consider any other equity investment.
Among other things, you should carefully consider the risks
described under the headings Risk Factors in this
prospectus supplement, the accompanying prospectus and the
documents incorporated by reference herein.
If the
rights offering is not completed, will my subscription payment
be refunded to me?
Yes. The subscription agent will hold all funds it receives in a
segregated bank account until completion of the rights offering.
If the rights offering is not completed, all subscription
payments received by the subscription agent will be returned,
without interest, as soon as practicable. If you own shares in
street name, it may take longer for you to receive
payment because the subscription agent will return payments
through the record holder of the shares.
vii
Will the
subscription rights be listed on a stock exchange or national
market?
The subscription rights may not be sold, transferred or assigned
and will not be listed for trading on The NASDAQ Global Market
or on any stock exchange or market or on the OTC
Bulletin Board. Our common stock and warrants will continue
to trade on The NASDAQ Global Market under the symbols
XIDE and XIDEW, respectively.
How do I
exercise my subscription rights if I live outside the United
States?
We will not mail this prospectus supplement or the rights
certificates to stockholders whose addresses are outside the
United States or who have an army post office or foreign post
office address. The subscription agent will hold the rights
certificates for their account. To exercise subscription rights,
our foreign stockholders must notify the subscription agent and
timely follow the procedures described in Rights
Offering Foreign Stockholders.
What fees
or charges apply if I purchase shares of our common
stock?
We are not charging any fee or sales commission to issue
subscription rights to you or to issue shares to you if you
exercise your subscription rights. If you exercise your
subscription rights through the record holder of your shares,
you are responsible for paying any fees your record holder may
charge you.
What are
the U.S. federal income tax consequences of exercising
subscription rights?
For U.S. federal income tax purposes, you will not
recognize taxable income as a result of the distribution or
exercise of your subscription rights unless the rights offering
is part of a disproportionate distribution within
the meaning of applicable tax rules (in which case you may
recognize taxable income upon receipt of the subscription
rights). We intend to take the position that the rights offering
will not be part of a disproportionate distribution, but certain
aspects of that determination are unclear. For further
information, please see U.S. Federal Income Tax
Consequences. You should, and are urged to, seek specific
advice from your personal tax advisor concerning the tax
consequences of the rights offering under your own tax situation.
To whom
should I send my forms and payment?
If your shares are held in the name of a broker, dealer or other
nominee, then you should send your subscription documents,
rights certificate, notices of guaranteed delivery and
subscription payment to that record holder. If you are the
record holder, then you should send your subscription documents,
rights certificate, notices of guaranteed delivery and
subscription payment by hand delivery, first class mail or
courier service to:
|
|
|
By Mail or Overnight
Courier:
American Stock
Transfer & Trust Company
Operations Center
Attn: Reorganization Department
6201 15th Avenue
Brooklyn, New York 11219
|
|
By Hand:
American Stock Transfer
& Trust Company
Attn: Reorganization Department
59 Maiden Lane
New York, New York 10038
|
You are solely responsible for completing delivery to the
subscription agent of your subscription documents, rights
certificate and payment. We urge you to allow sufficient time
for delivery of your subscription materials to the subscription
agent.
Who
should I contact if I have other questions?
If you have other questions or need assistance, please contact
the information agent, Georgeson Inc., at
(888) 605-7606
or (212) 440-9800 for banks and brokerage firms.
viii
PROSPECTUS
SUPPLEMENT SUMMARY
This summary highlights information contained in or
incorporated by reference into this prospectus supplement and
the accompanying prospectus. This summary may not contain all of
the information that you should consider before deciding whether
or not you should exercise your subscription rights. You should
carefully read this prospectus supplement and the accompanying
prospectus, including the documents incorporated by reference,
which are described under the heading Incorporation by
Reference in this prospectus supplement and the
accompanying prospectus. References in this prospectus
supplement and the accompanying prospectus to Exide,
the Company, we, us and
our refer to Exide Technologies and its consolidated
subsidiaries.
Our
Business
We are a global producer and recycler of lead acid batteries. We
provide a comprehensive range of stored electrical energy
products and services for transportation and industrial
applications. Transportation markets include original-equipment
and aftermarket automotive, heavy-duty truck, agricultural and
marine applications. Industrial markets include batteries for
telecommunications systems, fuel-cell load leveling, electric
utilities, railroads, uninterruptible power supply, lift trucks,
mining and other commercial vehicles. Our many brands include
Exide®,
Absolyte®,
Centratm,
Classic®,
DETA®,
Fulmen®,
GNBtm,
Liberatortm,
Marathon®,
Sonnenschein®
and
Tudor®.
We are a Delaware corporation organized in 1966 to succeed to
the business of a New Jersey corporation founded in 1888. Our
principal executive offices are located at 13000 Deerfield
Parkway, Building 200, Alpharetta, Georgia 30004. Our phone
number is
(678) 566-9000.
More comprehensive information about us and our products is
available through our Internet website at www.exide.com. Except
for the documents incorporated by reference in this prospectus
supplement and the accompanying prospectus as described under
the heading Incorporation by Reference, the
information and other content contained on our website are not
incorporated by reference in this prospectus supplement or the
accompanying prospectus, and you should not consider them to be
a part of this prospectus supplement or the accompanying
prospectus.
S-1
The
Rights Offering
The following summary describes the principal terms of the
rights offering, but is not intended to be complete. See the
information under the heading The Rights Offering in
this prospectus supplement for a more detailed description of
the terms and conditions of the rights offering.
|
|
|
Securities Offered |
|
We are distributing to you, at no charge, one non-transferable
subscription right for each share of our common stock that you
owned as of 5:00 p.m., New York City time, on the record
date, either as a holder of record or, in the case of shares
held of record by brokers, dealers, custodian banks or other
nominees on your behalf, as a beneficial owner of such shares.
Assuming the contractual 49.9% ownership limitation applicable
to the standby purchasers is not reached, we expect the gross
proceeds from the rights offering and the transactions
contemplated by the standby purchase agreement to be
approximately $91.7 million. As a result of the contractual
49.9% ownership limitation applicable to the standby purchasers,
if no stockholders other than the standby purchasers exercise
their subscription rights, we would expect to receive gross
proceeds from the rights offering and the transactions
contemplated by the standby purchase agreement of approximately
$64.5 million. |
|
Basic Subscription Privilege |
|
The basic subscription privilege of each subscription right will
entitle you to purchase 0.22851 shares of our common stock
at a subscription price of $6.55 per full share. |
|
Over-Subscription Privilege |
|
In the event that you purchase all of the shares of common stock
available to you pursuant to your basic subscription privilege,
you may also choose to purchase a portion of any shares of our
common stock that are not purchased by our stockholders through
the exercise of their basic subscription privileges. The maximum
number of shares of our common stock that could be purchased by
you pursuant to your over-subscription privilege will be
determined according to the following formula based in part on
your percentage ownership of our outstanding common stock as of
5:00 p.m., New York City time, on the record date: (total
number of unsubscribed shares multiplied by your
ownership percentage of our outstanding common stock at the
record date divided by two). For example, if you owned 2%
of our outstanding common stock on the record date and you
properly exercised your basic subscription privilege in full,
you may purchase up to 1% of the unsubscribed shares with your
over-subscription privilege. |
|
Record Date |
|
5:00 p.m., New York City time, on August 30, 2007. |
|
Expiration of the Rights Offering |
|
5:00 p.m., New York City time, on September 28, 2007. |
|
Subscription Price |
|
$6.55 per full share, payable in cash, determined in
connection with negotiations among the parties to the standby
purchase agreement and a review of recent historical trading
prices of our common stock and the closing sales price of our
common stock on August 27, 2007. To be effective, any
payment related to the exercise of a right must clear prior to
the expiration of the rights offering. |
S-2
|
|
|
Use of Proceeds |
|
We intend to use the proceeds of the rights offering to provide
additional liquidity for working capital, capital expenditures,
strategic opportunities, additional restructuring activities and
general corporate purposes. |
|
Non-Transferability of Rights |
|
The subscription rights may not be sold, transferred or assigned
and will not be listed for trading on The NASDAQ Global Market
or on any stock exchange or market or on the OTC
Bulletin Board. |
|
No Board Recommendation |
|
Our board of directors is making no recommendation regarding
your exercise of the subscription rights. You are urged to make
your decision based on your own assessment of our business and
the rights offering. Please see Risk Factors for a
discussion of some of the risks involved in investing in our
common stock. |
|
Standby Purchase Agreement |
|
In connection with the rights offering, we have entered into a
standby purchase agreement with the standby purchasers. Subject
to certain conditions, the standby purchase agreement obligates
us to sell, and requires the standby purchasers to purchase from
us, all of the shares purchasable with their basic subscription
privileges. Each of the standby purchasers has agreed not to
exercise its over-subscription privilege in any amount. In
addition, the standby purchase agreement obligates us to sell,
and requires the standby purchasers to purchase from us, any and
all shares of our common stock issuable upon the deemed exercise
by the standby purchasers immediately prior to the expiration of
the rights offering of any subscription rights that were not
exercised by other stockholders prior to the expiration of the
rights offering. The price per full share paid by the standby
purchasers for such common stock will be equal to the
subscription price paid by the stockholders in the rights
offering. |
|
|
|
Under the terms of the standby purchase agreement, the standby
purchasers have agreed to the contractual 49.9% ownership
limitation that restricts them from owning in the aggregate
shares of our common stock on the closing date of the
transactions contemplated by the standby purchase agreement in
an amount that exceeds 49.9% of the total outstanding shares of
our common stock on that date. As a result, if no other
stockholders exercise their subscription rights, based on the
amount of our outstanding common stock owned in the aggregate by
the standby purchasers as of August 28, 2007, this
contractual 49.9% ownership limitation would limit the amount of
common stock that would be issued to the standby purchasers
pursuant to the standby purchase agreement. Under the standby
purchase agreement, two-thirds of the unsubscribed shares will
be allocated to Tontine and one-third of the unsubscribed shares
will be allocated to Legg Mason. |
|
No Revocation |
|
All exercises of subscription rights are irrevocable, even if
you later learn information that you consider to be unfavorable
to the exercise of your subscription rights. You should not
exercise your subscription rights unless you are certain that
you wish to purchase additional shares of our common stock at a
subscription price of $6.55 per full share. |
S-3
|
|
|
U.S. Federal Income Tax Considerations |
|
For U.S. federal income tax purposes, you will not recognize
taxable income as a result of the distribution or exercise of
your subscription rights unless the rights offering is part of a
disproportionate distribution within the meaning of
applicable tax rules (in which case you may recognize taxable
income upon receipt of the subscription rights). We intend to
take the position that the rights offering will not be part of a
disproportionate distribution, but certain aspects of that
determination are unclear. For further information, please see
U.S. Federal Income Tax Consequences. You should,
and are urged to, seek specific advice from your personal tax
advisor concerning the tax consequences of the rights offering
under your own tax situation. |
|
Extension, Cancellation and Amendment |
|
We have the option, with the approval of the standby purchasers,
to extend the rights offering and the period for exercising your
subscription rights for a period not to exceed 15 days,
although we do not presently intend to do so. Our board of
directors may cancel the rights offering at any time prior to
the expiration of the rights offering for any reason. In the
event that the rights offering is cancelled, all subscription
payments received by the subscription agent will be returned,
without interest, as soon as practicable. We also reserve the
right to amend or modify the terms of the rights offering. |
|
Procedures for Exercising Rights |
|
To exercise your subscription rights, you must complete the
rights certificate and deliver it to the subscription agent,
American Stock Transfer & Trust Company, together
with full payment for all the subscription rights you elect to
exercise under the basic subscription privilege and
over-subscription privilege. You may deliver the documents and
payments by mail or commercial carrier. If regular mail is used
for this purpose, we recommend using registered mail, properly
insured, with return receipt requested. |
|
|
|
If you cannot deliver your rights certificate to the
subscription agent prior to the expiration of the rights
offering, you may follow the guaranteed delivery procedures
described under The Rights Offering Guaranteed
Delivery Procedures. |
|
Subscription Agent |
|
American Stock Transfer & Trust Company. |
|
Information Agent |
|
Georgeson Inc. |
|
Shares Outstanding Before the Rights Offering |
|
61,266,314 shares of our common stock were outstanding as
of August 28, 2007. |
|
Shares Outstanding After Completion of the Rights Offering
|
|
Assuming no options, warrants or convertible notes are exercised
prior to the expiration of the rights offering, and assuming the
standby purchasers do not reach their contractual 49.9%
ownership limitation, we expect approximately
75,266,314 shares of our common stock will be outstanding
immediately after completion of the rights offering and the
closing of the transactions contemplated by the standby purchase
agreement. |
S-4
|
|
|
|
|
As a result of the contractual 49.9% ownership limitation
applicable to the standby purchasers, if no stockholders other
than the standby purchasers exercise their subscription rights,
we expect approximately 71,117,789 shares of our common stock
will be outstanding immediately after completion of the rights
offering and the closing of the transactions contemplated by the
standby purchase agreement. |
|
Risk Factors |
|
Stockholders considering making an investment by exercising
subscription rights in the rights offering should carefully read
and consider the information set forth in Risk
Factors beginning on
page S-6
of this prospectus supplement and on page 2 of the
accompanying prospectus and the risk factors set forth in our
Annual Report on
Form 10-K
for the fiscal year ended March 31, 2007, the documents
incorporated by reference herein and the risks that we have
highlighted in other sections of this prospectus supplement and
the accompanying prospectus. |
|
Fees and Expenses |
|
We will pay the fees and expenses related to the rights
offering, including the fees and expenses of the standby
purchasers and their respective counsel. |
|
NASDAQ Global Market Trading Symbol |
|
Shares of our common stock are currently listed for quotation on
The NASDAQ Global Market under the symbol XIDE. |
Risk
Factors
Before you invest in the rights offering, you should be aware
that there are risks associated with your investment, including
the risks described in the section entitled Risk
Factors beginning on
page S-6
of this prospectus supplement and page 2 of the
accompanying prospectus, the risk factors set forth in our
annual report on
Form 10-K
for the fiscal year ended March 31, 2007 and our quarterly
report on
Form 10-Q
for the quarter ended June 30, 2007, and the risks that we
have highlighted in other sections of this prospectus supplement
and the accompanying prospectus. You should carefully read and
consider these risk factors together with all of the other
information included in or incorporated by reference into this
prospectus supplement and the accompanying prospectus before you
decide to exercise your subscription rights to purchase shares
of our common stock.
S-5
An investment in our common stock involves a high degree of
risk. You should carefully consider the risks described below,
together with the other information included or incorporated by
reference in this prospectus supplement and the accompanying
prospectus, including the risk factors set forth in our annual
report on
Form 10-K
for the fiscal year ended March 31, 2007, our quarterly
report on
Form 10-Q
for the quarter ended June 30, 2007 and the risks that we
have highlighted in other sections of this prospectus supplement
and the accompanying prospectus, before making a decision to
invest in our common stock. The risks described below are not
the only risks we face. Additional risks and uncertainties not
currently known to us or that we currently deem to be immaterial
may also materially and adversely affect our business
operations. If any of these risks actually occur, our business,
results of operations and financial condition could suffer. In
that case, the market price of our common stock could decline,
and you may lose all or part of your investment.
Risks
Related to the Rights Offering
The
market price of our common stock is volatile and may decline
before or after the subscription rights expire.
The market price of our common stock could be subject to wide
fluctuations in response to numerous factors, some of which are
beyond our control. These factors include, among other things,
actual or anticipated variations in our costs of doing business,
operating results and cash flow, the nature and content of our
earnings releases and our competitors earnings releases,
announcements of technological innovations that impact our
services, customers, competitors or markets, changes in
financial estimates by securities analysts, business conditions
in our markets and the general state of the securities markets
and the market for similar stocks, changes in capital markets
that affect the perceived availability of capital to companies
in our industries, governmental legislation or regulation,
currency and exchange rate fluctuations, as well as general
economic and market conditions, such as recessions.
We cannot assure you that the market price of our common stock
will not decline after you elect to exercise your subscription
rights. If that occurs, you may have committed to buy shares of
our common stock in the rights offering at a price greater than
the prevailing market price, and could have an immediate
unrealized loss. Moreover, we cannot assure you that following
the exercise of your subscription rights you will be able to
sell your common stock at a price equal to or greater than the
subscription price. Until shares are delivered upon expiration
of the rights offering, you will not be able to sell the shares
of our common stock that you purchase in the rights offering.
Certificates representing shares of our common stock purchased
will be delivered as soon as practicable after expiration of the
rights offering. We will not pay you interest on funds delivered
to the subscription agent pursuant to the exercise of
subscription rights.
If you
do not fully exercise your subscription rights, your ownership
interest will be diluted.
The rights offering will result in our issuance of approximately
14,000,000 shares of our common stock. If you choose not to
fully exercise your subscription rights prior to the expiration
of the rights offering, your relative ownership interest in us
will be diluted.
The standby purchasers have entered into a standby purchase
agreement with us that, subject to certain conditions, obligates
us to sell, and requires the standby purchasers to purchase from
us, all of the shares purchasable with their basic subscription
privileges. In addition, the standby purchase agreement
obligates us to sell, and requires the standby purchasers to
purchase from us, any and all shares of our common stock
issuable upon the deemed exercise by the standby purchasers
immediately prior to the expiration of the rights offering of
any subscription rights that were not exercised by other
stockholders prior to the expiration of the rights offering. As
a result of the contractual 49.9% ownership limitation
applicable to the standby purchasers on the closing date of the
transactions contemplated by the standby purchase agreement, if
no stockholders other than the standby purchasers exercise their
subscription rights, the aggregate beneficial ownership of the
standby purchasers in our outstanding common stock would
increase from 41.8% to 49.9%.
S-6
In addition, in connection with the rights offering, we will be
required to make downward anti-dilution adjustments to the
conversion price for our outstanding convertible notes and the
exercise price for our outstanding warrants. Accordingly, you
may also be subject to increased dilution from the conversion of
convertible notes or exercise of warrants to the extent the note
holders or warrant holders convert or exercise such securities.
If the
rights offering is consummated, our common stock will likely be
further concentrated in the hands of a few of our stockholders,
and their interests may not coincide with yours.
In connection with the rights offering, we entered into a
standby purchase agreement with Tontine and Legg Mason. As of
August 28, 2007, Tontine and Legg Mason beneficially owned
28.0% and 13.8% of our outstanding common stock, respectively.
If all of the subscription rights distributed to our
stockholders in the rights offering are exercised, the
beneficial ownership percentage of Tontine and Legg Mason will
remain the same. If any subscription rights remain unexercised
upon the expiration of the rights offering, the standby
purchasers will be deemed to have exercised those subscription
rights immediately prior to the expiration of the rights
offering and will purchase, at the subscription price of $6.55
per full share, the shares of our common stock that would have
been issued to our stockholders had they exercised such
subscription rights prior to the expiration of the rights
offering. If none of the subscription rights are exercised by
stockholders other than the standby purchasers, as a result of
the contractual 49.9% ownership limitation applicable to the
standby purchasers, Tontine and Legg Mason are expected to own,
respectively, approximately 33.4% and 16.5% of our outstanding
common stock.
Tontine and Legg Mason and their respective affiliates currently
have the ability to exercise significant influence over matters
generally requiring stockholder approval. These matters include
the election of directors and the approval of significant
corporate transactions, including potential mergers,
consolidations or sales of all or substantially all of our
assets. Upon completion of the rights offering, this influence
is likely to be further increased due to the standby commitments
from the standby purchasers. Your interests as a holder of our
common stock may differ from the interests of Tontine and Legg
Mason and their respective affiliates.
After
the consummation of the rights offering, the standby purchasers
may have significantly increased their ownership of our common
stock and certain further acquisitions of our common stock by
them could result in an acceleration of our outstanding credit
facilities.
Under the credit agreement governing our senior secured credit
facility, a change of control is deemed to have occurred if any
person or group acquires 40% or more of the voting or economic
interest in our capital stock. Under the indentures governing
our senior notes and convertible notes, a change in control is
deemed to have occurred if any person or group acquires more
than 50% of the voting power represented by our issued and
outstanding capital stock. If a change of control under our
credit agreement or indenture is deemed to occur, the credit
agreement lenders may require immediate payment of our
outstanding borrowings and the noteholders can require us to
purchase their notes. Such actions would have a material adverse
effect on our business and financial condition. Although the
number of shares of our common stock that the standby purchasers
can purchase under the standby purchase agreement is limited so
that their ownership will not exceed these thresholds on the
closing date of the transactions contemplated by the standby
purchase agreement, there is no restriction on either of the
standby purchasers ability to purchase additional shares
of our common stock after the closing of the transactions
contemplated by the standby purchase agreement. As a result,
future purchases of our common stock by either of the standby
purchasers could trigger one or both of these thresholds. In
addition, if the standby purchasers take action in the future
which causes them to be deemed to be a group for these purposes,
their combined ownership of our outstanding common stock could
trigger these thresholds. There can be no assurance one or both
of these thresholds will not be exceeded in the future.
The
subscription rights are not transferable and there is no market
for the subscription rights.
You may not sell, transfer or assign your subscription rights.
The subscription rights are only transferable by operation of
law. Because the subscription rights are non-transferable, there
is no market or other means for you to directly realize any
value associated with the subscription rights. You must exercise
the subscription
S-7
rights and acquire additional shares of our common stock to
realize any value that may be embedded in the subscription
rights.
The
subscription price determined for the rights offering is not an
indication of the fair value of our common stock.
Our board of directors determined the terms of the rights
offering and the transactions contemplated by the standby
purchase agreement after negotiations among the parties to the
standby purchase agreement. In determining the subscription
price, our board of directors considered a number of factors,
including: the likely cost of capital from other sources, the
price at which our stockholders might be willing to participate
in the rights offering, historical and current trading prices
for our common stock, our need for liquidity and capital and the
desire to provide an opportunity to our stockholders to
participate in the rights offering on a pro rata basis. In
conjunction with its review of these factors, our board of
directors also reviewed a range of discounts to market value
represented by the subscription prices in various prior rights
offerings by other public companies. The per share subscription
price is not necessarily related to our book value, net worth or
any other established criteria of fair value and may or may not
be considered the fair value of our common stock to be offered
in the rights offering. After the date of this prospectus
supplement, our common stock may trade at prices above or below
the subscription price.
Because
our management will have broad discretion over the use of the
net proceeds from the rights offering, you may not agree with
how we use the proceeds, and we may not invest the proceeds
successfully.
While we currently anticipate that we will use the net proceeds
of the rights offering to provide additional liquidity for
working capital, capital expenditures and general corporate
purposes our management may allocate the proceeds among these
purposes as it determines is appropriate. In addition, market
factors may require our management to allocate portions of the
proceeds for other purposes. Accordingly, you will be relying on
the judgment of our management with regard to the use of the
proceeds from the rights offering, and you will not have the
opportunity, as part of your investment decision, to assess
whether the proceeds are being used appropriately. It is
possible that the proceeds will be invested in a way that does
not yield a favorable, or any, return for the Company.
We may
cancel the rights offering at any time prior to the expiration
of the rights offering, and neither we nor the subscription
agent will have any obligation to you except to return your
exercise payments.
We may, in our sole discretion, decide not to continue with the
rights offering or cancel the rights offering prior to the
expiration of the rights offering. If the rights offering is
cancelled, all subscription payments received by the
subscription agent will be returned, without interest, as soon
as practicable.
You
may not revoke your subscription exercise and could be committed
to buying shares above the prevailing market
price.
Once you exercise your subscription rights, you may not revoke
the exercise. The public trading market price of our common
stock may decline before the subscription rights expire. If you
exercise your subscription rights and, afterwards, the public
trading market price of our common stock decreases below the
subscription price, you will have committed to buying shares of
our common stock at a price above the prevailing market price.
Our common stock is traded on The NASDAQ Global Market under the
symbol XIDE, and the last reported sales price of
our common stock on The NASDAQ Global Market on August 27,
2007 was $7.02 per share. Moreover, you may be unable to sell
your shares of our common stock at a price equal to or greater
than the subscription price you paid for such shares.
If you
do not act promptly and follow the subscription instructions,
your exercise of subscription rights will be
rejected.
Stockholders that desire to purchase shares in the rights
offering must act promptly to ensure that all required forms and
payments are actually received by the subscription agent prior
to the expiration of the rights offering. If you are a
beneficial owner of shares, you must act promptly to ensure that
your broker, dealer, custodian bank or other nominee acts for
you and that all required forms and payments are actually
S-8
received by the subscription agent prior to the expiration of
the rights offering. We are not responsible if your broker,
custodian or nominee fails to ensure that all required forms and
payments are actually received by the subscription agent prior
to the expiration of the rights offering. If you fail to
complete and sign the required subscription forms, send an
incorrect payment amount or otherwise fail to follow the
subscription procedures that apply to your exercise in the
rights offering prior to the expiration of the rights offering,
the subscription agent will reject your subscription or accept
it only to the extent of the payment received. Neither we nor
our subscription agent undertake to contact you concerning an
incomplete or incorrect subscription form or payment, nor are we
under any obligation to correct such forms or payment. We have
the sole discretion to determine whether a subscription exercise
properly complies with the subscription procedures.
The
tax treatment of the rights offering is somewhat uncertain and
it may be treated as a taxable event to our
stockholders.
If the rights offering is deemed to be part of a
disproportionate distribution under section 305
of the Internal Revenue Code, our stockholders may recognize
taxable income for U.S. federal income tax purposes in
connection with the receipt of subscription rights in the rights
offering depending on our current and accumulated earnings and
profits and our stockholders basis in our common stock. A
disproportionate distribution is a distribution or a
series of distributions, including deemed distributions, that
has the effect of the receipt of cash or other property by some
stockholders or holders of debt instruments convertible into
stock and an increase in the proportionate interest of other
stockholders in a companys assets or earnings and profits.
Because we have outstanding notes convertible into our common
stock and on which we have paid interest, applicable Treasury
regulations provide that the receipt of the subscription rights
will be part of a disproportionate distribution unless a
full adjustment is made in the conversion price of
the notes to reflect the rights offering. It is unclear whether
the adjustment to the conversion price of the notes qualifies as
a full adjustment. It is also unclear whether the
fact that we also have outstanding options and warrants could
cause the receipt of subscription rights to be part of a
disproportionate distribution. Please see
U.S. Federal Income Tax Consequences for
further information on the treatment of the rights offering.
In addition, your tax basis in the subscription rights, in your
current shares of our common stock and in the shares of our
common stock that you acquire through exercise of the
subscription rights may be uncertain. Your tax basis in the
shares of our common stock acquired through exercise of the
subscription rights will equal the sum of the subscription price
for the shares and your tax basis, if any, in the subscription
rights. Your tax basis in the subscription rights will depend on
whether the rights offering is deemed to be part of a
disproportionate distribution, the fair market value of the
subscription rights and, if applicable, whether you elect to
allocate part of the tax basis of your common stock to the
subscription rights. Please see U.S. Federal Income
Tax Consequences for further information on these issues.
Risks
Related to Our Common Stock
Sales,
or the availability for sale, of substantial amounts of our
common stock could adversely affect the value of our common
stock.
No prediction can be made as to the effect, if any, that future
sales of our common stock, or the availability of our common
stock for future sales, will have on the market price of our
common stock. Sales of substantial amounts of our common stock
in the public market and the availability of shares for future
sale, including, as of August 28, 2007, approximately
6,053,965 shares of our common stock issuable upon exercise
of outstanding options to acquire shares of our common stock,
3,584,229 shares of our common stock that may be issued
upon conversion of our convertible notes and
6,621,165 shares covered by warrants issued and issuable
under our 2004 plan of reorganization (such share totals are not
adjusted for anti-dilution adjustments that may be triggered by
the rights offering), could adversely affect the prevailing
market price of our common stock. This in turn could impair our
future ability to raise capital through an offering of our
equity securities.
S-9
Assuming the contractual 49.9% ownership limitation applicable
to the standby purchasers is not reached, we estimate that the
net proceeds to us from the sale of our common stock offered in
the rights offering and the transactions contemplated by the
standby purchase agreement, after deducting estimated offering
expenses, will be approximately $91.0 million. However, as
a result of the contractual 49.9% ownership limitation
applicable to the standby purchasers on the closing date of the
transactions contemplated by the standby purchase agreement, if
no stockholders other than the standby purchasers exercise their
subscription rights, we instead would expect proceeds to us from
the sale of our common stock offered in the rights offering and
the transactions contemplated by the standby purchase agreement,
after deducting estimated offering expenses, would be
approximately $63.8 million. We intend to use these
proceeds to provide additional liquidity for working capital,
capital expenditures, strategic opportunities, additional
restructuring activities and general corporate purposes.
S-10
The following table sets forth our cash and cash equivalents and
our capitalization as of June 30, 2007 on an actual basis
and as adjusted to give effect to the rights offering and the
transactions contemplated by the standby purchase agreement,
after deducting the estimated offering expenses and the proposed
application of the net proceeds therefrom, assuming the
contractual 49.9% limitation applicable to the standby
purchasers is not reached. Please see Use of
Proceeds. You should read this table together with the
information under the heading Managements Discussion
and Analysis of Results of Operations and Financial
Condition and our unaudited interim consolidated financial
statements and related notes and other financial information
incorporated by reference to our quarterly report on
Form 10-Q
for the quarter ended June 30, 2007.
|
|
|
|
|
|
|
|
|
|
|
As of June 30, 2007
|
|
|
|
Actual
|
|
|
As Adjusted
|
|
|
|
(Unaudited)
|
|
|
|
(In thousands)
|
|
|
Cash and cash equivalents
|
|
$
|
49,340
|
|
|
$
|
140,290
|
|
|
|
|
|
|
|
|
|
|
Debt (including current portion):
|
|
|
|
|
|
|
|
|
Senior secured credit facility
|
|
|
365,305
|
|
|
|
365,305
|
|
Capital lease obligations and
other borrowings(1)
|
|
|
25,526
|
|
|
|
25,526
|
|
Short-term borrowings
|
|
|
14,946
|
|
|
|
14,946
|
|
Outstanding notes
|
|
|
290,000
|
|
|
|
290,000
|
|
|
|
|
|
|
|
|
|
|
Total senior debt (including
current portion)
|
|
$
|
695,777
|
|
|
|
695,777
|
|
Convertible senior subordinated
notes
|
|
|
60,000
|
|
|
|
60,000
|
|
|
|
|
|
|
|
|
|
|
Total debt
|
|
$
|
755,777
|
|
|
|
755,777
|
|
Minority interest
|
|
|
15,137
|
|
|
|
15,137
|
|
Stockholders equity:
|
|
|
|
|
|
|
|
|
Common stock, $0.01 par
value, 100,000 shares authorized; 61,210 shares issued
and outstanding; 75,210 shares issued and outstanding as
adjusted
|
|
|
612
|
|
|
|
752
|
|
Preferred stock, $0.01 par
value, 1,000 shares authorized; no shares issued and
outstanding
|
|
|
|
|
|
|
|
|
Additional paid-in capital
|
|
|
1,009,802
|
|
|
|
1,100,612
|
|
Accumulated deficit
|
|
|
(785,403
|
)
|
|
|
(785,403
|
)
|
Accumulated other comprehensive
income (loss)
|
|
|
76,902
|
|
|
|
76,902
|
|
|
|
|
|
|
|
|
|
|
Total stockholders equity
|
|
$
|
301,913
|
|
|
$
|
392,863
|
|
|
|
|
|
|
|
|
|
|
Total capitalization
|
|
$
|
1,072,827
|
|
|
$
|
1,163,777
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(1) |
|
Includes various operating lines of credit and working capital
facilities maintained by our
non-U.S.
subsidiaries. |
S-11
Please read the following information concerning the
subscription rights in conjunction with the statements under
Description of Rights in the accompanying
prospectus, which the following information supplements and, in
the event of any inconsistencies, supersedes.
The
Subscription Rights
We are distributing to the record holders of our common stock as
of the record date non-transferable subscription rights to
purchase shares of our common stock. The subscription price of
$6.55 per full share was determined by our board of directors
after negotiations with the parties to the standby purchase
agreement and after a review of recent historical trading prices
of our common stock and the closing sales price of our common
stock on August 27, 2007. The subscription rights will
entitle the holders of our common stock to purchase
approximately an aggregate of 14,000,000 shares of our
common stock for an aggregate purchase price of
$91.7 million.
Each holder of record of our common stock will receive one
subscription right for each share of our common stock owned by
such holder at the as of 5:00 p.m., New York City time, on
the record date. Each subscription right will entitle the holder
to a basic subscription privilege and an over-subscription
privilege.
Basic
Subscription Privilege
With your basic subscription privilege, you may purchase
0.22851 shares of our common stock per subscription right,
upon delivery of the required documents and payment of the
subscription price of $6.55 per full share, prior to the
expiration of the rights offering. You may exercise all or a
portion of your basic subscription privilege, however, if you
exercise less than your full basic subscription privilege you
will not be entitled to purchase shares under your
over-subscription privilege. Under the standby purchase
agreement, the standby purchasers have agreed to exercise their
basic subscription privileges in full.
Fractional shares of our common stock resulting from the
exercise of the basic subscription privilege will be eliminated
by rounding down to the nearest whole share, with the total
subscription payment being adjusted accordingly. Any excess
subscription payments received by the subscription agent will be
returned, without interest, as soon as practicable.
We will deliver certificates representing shares of our common
stock purchased with the basic subscription privilege as soon as
practicable after the rights offering has expired.
Over-Subscription
Privilege
In the event that you purchase all of the shares of common stock
available to you pursuant to your basic subscription privilege,
you may also choose to purchase a portion of any shares of our
common stock that are not purchased by our stockholders through
the exercise of their basic subscription privileges. The maximum
number of shares of our common stock that could be purchased by
you pursuant to your over-subscription privilege will be
determined according to the following formula based in part on
your percentage ownership of our outstanding common stock as of
5:00 p.m., New York City time, on the record date: (total
number of unsubscribed shares multiplied by your
ownership percentage of our outstanding common stock at the
record date divided by two). For example, if you owned 2%
of our outstanding common stock on the record date and you
properly exercised your basic subscription privilege in full,
you may purchase up to 1% of the unsubscribed shares with your
over-subscription privilege.
In order to properly exercise your over-subscription privilege,
you must deliver the subscription payment related to your
over-subscription privilege prior to the expiration of the
rights offering. Because we will not know the total number of
unsubscribed shares prior to the expiration of the rights
offering, if you wish to maximize the number of shares you
purchase pursuant to your over-subscription privilege, you will
need to deliver payment in an amount equal to the aggregate
subscription price for the maximum number of shares of our
common stock available to you, assuming that no stockholder
other than you and the standby purchasers
S-12
(who have agreed to exercise their basic subscription privileges
in full) has purchased any shares of our common stock pursuant
to their basic subscription privilege.
We can provide no assurances that you will actually be entitled
to purchase the number of shares issuable upon the exercise of
your over-subscription privilege in full at the expiration of
the rights offering. We will not be able to satisfy your
exercise of the over-subscription privilege if all of our
stockholders exercise their basic subscription privileges in
full, and we will only honor an over-subscription privilege to
the extent sufficient shares of our common stock are available
following the exercise of subscription rights under the basic
subscription privileges.
|
|
|
|
|
To the extent the aggregate subscription price of the maximum
number of unsubscribed shares available to you pursuant to the
over-subscription privilege is less than the amount you actually
paid in connection with the exercise of the over-subscription
privilege, you will be allocated only the number of unsubscribed
shares available to you, and any excess subscription payments
received by the subscription agent will be returned, without
interest, as soon as practicable.
|
|
|
|
To the extent the amount you actually paid in connection with
the exercise of the over-subscription privilege is less than the
aggregate subscription price of the maximum number of
unsubscribed shares available to you pursuant to the
over-subscription privilege, you will be allocated the number of
unsubscribed shares for which you actually paid in connection
with the over-subscription privilege.
|
Fractional shares of our common stock resulting from the
exercise of the over-subscription privilege will be eliminated
by rounding down to the nearest whole share, with the total
subscription payment being adjusted accordingly. Any excess
subscription payments received by the subscription agent will be
returned, without interest, as soon as practicable.
We will deliver certificates representing shares of our common
stock purchased with the over-subscription privilege as soon as
practicable after the expiration of the rights offering.
S-13
Effects
on Ownership of Certain Beneficial Owners and
Management
The following table sets forth information regarding the
beneficial ownership of our common stock as of August 28,
2007 by persons known to beneficially own more than 5% of our
common stock, our directors and our executive officers, and the
potential effects of the rights offering, assuming Tontine has
been allocated two-thirds of, and Legg Mason has been allocated
one-third of, the unsubscribed shares issued upon completion of
the rights offering and closing of the transactions contemplated
by the standby purchase agreement. In computing the number of
shares of our common stock beneficially owned by a person and
the percentage ownership of that person, we included outstanding
shares of our common stock subject to options or warrants held
by that person that are currently exercisable or exercisable
within 60 days of August 28, 2007. We did not deem
these shares outstanding, however, for purposes of computing the
number of shares that may be purchased in the rights offering by
such person or computing the percentage ownership of any other
person.
The information provided in the table below is based on our
records, information filed with the SEC and information provided
to us, except where otherwise noted.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Percentage
|
|
|
|
|
|
|
|
|
|
Percentage
|
|
|
of Class
|
|
|
|
|
|
|
|
|
|
of Class
|
|
|
if only Standby
|
|
|
|
Number of
|
|
|
|
|
|
if all Holders
|
|
|
Purchasers
|
|
|
|
Shares
|
|
|
|
|
|
Exercise
|
|
|
Exercise
|
|
|
|
Beneficially
|
|
|
Percent
|
|
|
Subscription
|
|
|
Subscription
|
|
Name of Beneficial Owner
|
|
Owned
|
|
|
of Class
|
|
|
Rights(1)
|
|
|
Rights(2)
|
|
|
5% Stockholders
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Jeffrey L. Gendell(3)
|
|
|
17,183,870
|
|
|
|
28.0
|
%
|
|
|
28.0
|
%
|
|
|
33.4
|
%
|
c/o Tontine
Capital Management, L.L.C.
55 Railroad Avenue, 1st Floor
Greenwich, CT 06830
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Legg Mason(4)
|
|
|
8,452,431
|
|
|
|
13.8
|
%
|
|
|
13.8
|
%
|
|
|
16.5
|
%
|
100 Light Street
Baltimore, MD 21202
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Directors and Executive
Officers(5)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Herbert F. Aspbury
|
|
|
24,054
|
|
|
|
|
*
|
|
|
|
*
|
|
|
|
*
|
Michael R. DAppolonia
|
|
|
41,684
|
|
|
|
|
*
|
|
|
|
*
|
|
|
|
*
|
David S. Ferguson
|
|
|
37,224
|
|
|
|
|
*
|
|
|
|
*
|
|
|
|
*
|
Paul W. Jennings
|
|
|
26,054
|
|
|
|
|
*
|
|
|
|
*
|
|
|
|
*
|
Joseph V. Lash(6)
|
|
|
0
|
|
|
|
|
*
|
|
|
|
*
|
|
|
|
*
|
John P. Reilly
|
|
|
41,684
|
|
|
|
|
*
|
|
|
|
*
|
|
|
|
*
|
Michael P. Ressner
|
|
|
37,139
|
|
|
|
|
*
|
|
|
|
*
|
|
|
|
*
|
Gordon A. Ulsh(7)
|
|
|
946,115
|
|
|
|
1.5
|
%
|
|
|
1.5
|
%
|
|
|
1.3
|
%
|
Carroll R. Wetzel
|
|
|
37,224
|
|
|
|
|
*
|
|
|
|
*
|
|
|
|
*
|
Francis M. Corby
|
|
|
92,182
|
|
|
|
|
*
|
|
|
|
*
|
|
|
|
*
|
Mitchell S. Bregman
|
|
|
96,172
|
|
|
|
|
*
|
|
|
|
*
|
|
|
|
*
|
Phillip A. Damaska
|
|
|
68,588
|
|
|
|
|
*
|
|
|
|
*
|
|
|
|
*
|
Edward J. OLeary
|
|
|
104,096
|
|
|
|
|
*
|
|
|
|
*
|
|
|
|
*
|
All directors and executive
officers as a group (18 persons)
|
|
|
1,885,691
|
|
|
|
3.1
|
%
|
|
|
3.1
|
%
|
|
|
2.6
|
%
|
|
|
|
(1) |
|
Because each subscription right carries a basic subscription
privilege and an over-subscription privilege, the maximum number
of shares that any stockholder may purchase in this offering
depends in part on the number of shares purchased by other
stockholders. The figures in this column assume that all
stockholders exercise all subscription rights issued to them. |
S-14
|
|
|
(2) |
|
The total ownership of the standby purchasers is subject to the
contractual 49.9% ownership limitation applicable to the standby
purchasers. |
|
(3) |
|
The information reflects the Schedule 13D filed jointly by
Jeffrey L. Gendell and the entities described below on
September 20, 2006. Mr. Gendell is the managing member
of Tontine Capital Management, L.L.C., or TCM, a Delaware
limited liability company, the general partner of Tontine
Capital Partners, L.P., a Delaware limited partnership, or TCP.
Mr. Gendell is the managing member of Tontine Management,
L.L.C., or TM, a Delaware limited liability company, the general
partner of Tontine Partners, L.P., a Delaware limited
partnership, or TP. Mr. Gendell is also the managing member
of Tontine Overseas Associates, L.L.C., a Delaware limited
liability company, or TOA, the investment advisor to Tontine
Overseas Fund, Ltd., a Cayman Islands corporation, or TOF, and
certain separately managed accounts. Mr. Gendell is also
the managing member of Tontine Capital Overseas GP, L.L.C., a
Delaware limited liability company, or TCO, the general partner
of Tontine Capital Overseas Master Fund, L.P., a Cayman Islands
limited partnership, or TMF. Mr. Gendell indirectly owns
17,183,870 shares of our common stock which is made up of
the following: TCP directly owns 8,002,971 shares of our
common stock; TP directly owns 5,798,717 shares of our
common stock; TMF directly owns 900,000 shares of our
common stock; TOF beneficially owns 2,389,305 shares of our
common stock; and certain separately managed accounts own
92,877 shares of our common stock. All of the foregoing
shares of our common stock may be deemed to be beneficially
owned by Mr. Gendell. Mr. Gendell disclaims beneficial
ownership of such shares of our common stock for purposes of
Section 16(a) of the Securities Exchange Act of 1934, as
amended, or the Exchange Act, or otherwise, except as to
securities representing Mr. Gendells pro rata
interest in, and interest in the profits of, TCP, TP, TM, TOA,
TMF and TOF. |
|
(4) |
|
The information reflects the Schedule 13G filed by LMM LLC
and Legg Mason Opportunity Trust, a portfolio of Legg Mason
Investment Trust, Inc., on February 15, 2007. |
|
(5) |
|
Includes shares of our common stock that may be acquired by
exercise of stock options within 60 days of August 28,
2007 as follows: Messrs. Aspury and Jennings,
13,290 shares each; Messrs. DAppolonia,
Reilly and Ressner, 21,075 shares each;
Messrs. Ferguson and Wetzel, 18,963 shares each;
Mr. Ulsh, 330,376 shares; Mr. Bregman,
52,174 shares; Mr. Damaska, 24,968 shares;
Mr. OLeary, 43,095 shares; and all directors and
executive officers as a group, 734,782 shares. |
|
(6) |
|
Mr. Lash is employed by an affiliate of Tontine, and
Mr. Lash disclaims beneficial ownership of any shares of
our common stock held by Mr. Gendell or any affiliate of
Tontine. |
|
(7) |
|
Includes 257,057 shares transferred to the Gordon A. Ulsh
and Laurie J. Ulsh, J/R/L/T/A, dated June 21, 1996, as
amended, of which Mr. Ulsh and his spouse are trustees.
Mr. Ulsh continues to report beneficial ownership of shares
of the issuer held for the account of the trust but disclaims
beneficial ownership (except to the extent of the pecuniary
interest of Mr. Ulsh and his spouse) in the trust. |
Reasons
for the Rights Offering
In authorizing the rights offering, our board of directors
carefully evaluated our need for liquidity, financial
flexibility and additional capital. Our board of directors also
considered several alternative capital raising methods prior to
concluding that the rights offering was the appropriate
alternative under the circumstances. We are conducting the
rights offering to raise capital that we intend to use to
provide additional liquidity for working capital, capital
expenditures and general corporate purposes. We believe that the
rights offering will strengthen our financial condition by
generating additional cash and increasing our stockholders
equity. Although we believe that the rights offering will
strengthen our financial condition, our board of directors is
making no recommendation regarding your exercise of the
subscription rights.
Standby
Commitments
On August 28, 2007, we entered into a standby purchase
agreement with the standby purchasers in connection with the
rights offering. The following description of the standby
purchase agreement summarizes certain terms of the standby
purchase agreement. A copy of the standby purchase agreement has
been filed as an exhibit to our Current Report on
Form 8-K
filed on August 28, 2007. We urge you to carefully read the
entire document.
S-15
Subject to certain conditions, the standby purchase agreement
obligates us to sell, and requires the standby purchasers to
purchase from us, all of the shares purchasable with their basic
subscription privileges. Each of the standby purchasers has
agreed not to exercise its over-subscription privilege in any
amount. In addition, the standby purchase agreement obligates us
to sell, and requires the standby purchasers to purchase from
us, any and all shares of our common stock issuable upon the
deemed exercise by the standby purchasers immediately prior to
the expiration of the rights offering of any subscription rights
that were not exercised by other stockholders prior to the
expiration of the rights offering. The price per full share paid
by the standby purchasers for such common stock will be equal to
the subscription price paid by our stockholders in the rights
offering.
Under the terms of the standby purchase agreement, the standby
purchasers have agreed to a maximum ownership limitation,
referred to in this prospectus as the contractual 49.9%
ownership limitation, that restricts them from owning in the
aggregate shares of our common stock on the closing date of the
transactions contemplated by the standby purchase agreement in
an amount that exceeds 49.9% of the total outstanding shares of
our common stock on that date. As a result, if no other
stockholders exercise their subscription rights, based on the
amount of our outstanding common stock owned in the aggregate by
the standby purchasers as of August 28, 2007, this
contractual 49.9% ownership limitation would limit the amount of
common stock that would be issued to the standby purchasers
pursuant to the standby purchase agreement. Under the standby
purchase agreement, two-thirds of the unsubscribed shares will
be allocated to Tontine and one-third of the unsubscribed shares
will be allocated to Legg Mason. Although we do not currently
intend to do so, we are entitled to waive the contractual 49.9%
ownership limitation in connection with the closing of the
transactions contemplated by the standby purchase agreement.
The obligation of the standby purchasers to fulfill the standby
commitments under the standby purchase agreement is subject to
the following conditions:
|
|
|
|
|
our representations and warranties under the standby purchase
agreement are true and correct in all material respects as of
the date of the standby purchase agreement and the date of the
closing of the transactions contemplated thereunder;
|
|
|
|
any applicable waiting period under the Hart-Scott-Rodino
Antitrust Improvements Act of 1976, as amended, shall have
expired or been terminated thereunder with respect to any of the
standby purchasers commitments;
|
|
|
|
there having been no material adverse effect on our financial
condition or earnings, financial position, operations, assets,
results of operations, business or prospects and there having
occurred no event or circumstance that would reasonably likely
result in such a material adverse effect;
|
|
|
|
there having occurred none of the following events: (1) a
suspension of trading of our common stock or a suspension of
trading or the establishment of limited or minimum prices on
securities generally on the New York Stock Exchange or The
NASDAQ Global Market; (2) a banking moratorium having been
declared either by U.S. federal or New York State
authorities; or (3) any material outbreak or material
escalation of hostilities, declaration by the United States of a
national emergency or war or other calamity or crisis which has
a material adverse effect on the U.S. financial markets,
each of which we refer to as a market event.
|
Each of the standby purchasers has agreed that they will not
purchase shares in the rights offering or the transactions
contemplated by the standby purchase agreement that would result
in either of them individually or any group (within
the meaning of Section 13(d)(3) of the Exchange Act) of
which they are a member owning (1) 40% or more of the
issued and outstanding shares of our common stock without the
requisite prior written consent of our lenders under our senior
secured credit facility or (2) greater than 49.9% of the
issued and outstanding shares of our common stock.
From the commencement of the rights offering until the
expiration of the rights offering, neither of the standby
purchasers nor any of their respective affiliates over which
they exercise investment authority may acquire any shares of our
common stock; provided, however, that the foregoing will not
restrict the acquisition of shares of our common stock by the
standby purchasers or their respective affiliates (1) from
us pursuant to the standby purchase agreement or (2) from
the standby purchasers or one or more of their respective
affiliates. Legg Mason
S-16
has also agreed, pursuant to a separate non-disclosure
agreement, not to acquire or sell any shares of our common stock
through September 30, 2007.
As of August 28, 2007, Tontine and Legg Mason beneficially
owned 17,183,870 and 8,452,431 shares of our common stock,
consisting of approximately 28.0% and 13.8% of our issued and
outstanding common stock, respectively. Accordingly, the audit
committee of our board of directors has reviewed the standby
purchase agreement under our corporate governance guidelines, as
well as our related party transaction policy.
Each of the standby purchasers has represented to us that they
are not affiliates of the other within the meaning
of Rule 405 of the Securities Act and are not acting in
concert with each other and are not members of a
group (within the meaning of Section 13(d)(3)
of the Exchange Act) and have no current intention to act in the
future in a manner that would make them members of such a group.
Each standby purchaser may assign its obligations under the
standby purchase agreement to any affiliate over which such
standby purchaser exercises investment authority, including with
respect to voting and dispositive rights, as long as the
affiliate assumes such obligations and agrees to be bound by the
terms of the standby purchase agreement.
Method of
Exercising Subscription Rights
The exercise of subscription rights is irrevocable and may not
be cancelled or modified. You may exercise your subscription
rights as follows:
Subscription
by Registered Holders
You may exercise your subscription rights by properly completing
and executing the rights certificate together with any required
signature guarantees and forwarding it, together with your full
subscription payment, to the subscription agent at the address
set forth below under Subscription
Agent, prior to the expiration of the rights offering.
Subscription
by DTC Participants
We expect that the exercise of your subscription rights may be
made through the facilities of DTC. If your subscription rights
are held of record through DTC, you may exercise your
subscription rights by instructing DTC, or having your broker
instruct DTC, to transfer your subscription rights from your
account to the account of the subscription agent, together with
certification as to the aggregate number of subscription rights
you are exercising and the number of shares of our common stock
you are subscribing for under your basic subscription privilege
and your over-subscription privilege, if any, and your full
subscription payment.
Subscription
by Beneficial Owners
If you are a beneficial owner of shares of our common stock that
are registered in the name of a broker, custodian bank or other
nominee, or if you hold our common stock certificates and would
prefer to have an institution conduct the transaction relating
to the subscription rights on your behalf, you should instruct
your broker, custodian bank or other nominee or institution to
exercise your subscription rights and deliver all documents and
payment on your behalf prior to 5:00 p.m., New York City
time, on September 28, 2007, which is the expiration of the
rights offering. Your subscription rights will not be considered
exercised unless the subscription agent receives from you, your
broker, custodian bank, nominee or institution, as the case may
be, all of the required documents and your full subscription
payment prior to 5:00 p.m., New York City time, on
September 28, 2007.
Payment
Method
Payments must be made in full in U.S. currency by:
|
|
|
|
|
check or bank draft payable to American Stock
Transfer & Trust Company, or the subscription
agent, drawn upon a U.S. bank;
|
S-17
|
|
|
|
|
postal, telegraphic or express money order payable to the
subscription agent; or
|
|
|
|
wire transfer of immediately available funds to accounts
maintained by the subscription agent.
|
Payment received after the expiration of the rights offering
will not be honored, and the subscription agent will return your
payment to you, without interest, as soon as practicable. The
subscription agent will be deemed to receive payment upon:
|
|
|
|
|
clearance of any uncertified check deposited by the subscription
agent;
|
|
|
|
receipt by the subscription agent of any certified check bank
draft drawn upon a U.S. bank;
|
|
|
|
receipt by the subscription agent of any postal, telegraphic or
express money order; or
|
|
|
|
receipt of collected funds in the subscription agents
account.
|
If you elect to exercise your subscription rights, we urge you
to consider using a certified or cashiers check, money
order, or wire transfer of funds to ensure that the subscription
agent receives your funds prior to the expiration of the rights
offering. If you send an uncertified check, payment will not be
deemed to have been received by the subscription agent until the
check has cleared, but if you send a certified check bank draft
drawn upon a U.S. bank, a postal, telegraphic or express
money order or wire or transfer funds directly to the
subscription agents account, payment will be deemed to
have been received by the subscription agent immediately upon
receipt of such instruments and wire or transfer.
Any personal check used to pay for shares of our common stock
must clear the appropriate financial institutions prior to
5:00 p.m., New York City time, on September 28, 2007,
which is the expiration of the rights offering. The
clearinghouse may require five or more business days.
Accordingly, holders that wish to pay the subscription price by
means of an uncertified personal check are urged to make payment
sufficiently in advance of the expiration of the rights offering
to ensure such payment is received and clears by such date.
You should read the instruction letter accompanying the rights
certificate carefully and strictly follow it. DO NOT SEND RIGHTS
CERTIFICATES OR PAYMENTS TO US. Except as described below under
Guaranteed Delivery Procedures, we will
not consider your subscription received until the subscription
agent has received delivery of a properly completed and duly
executed rights certificate and payment of the full subscription
amount. The risk of delivery of all documents and payments is
borne by you or your nominee, not by the subscription agent or
us.
The method of delivery of rights certificates and payment of the
subscription amount to the subscription agent will be at the
risk of the holders of subscription rights. If sent by mail, we
recommend that you send those certificates and payments by
overnight courier or by registered mail, properly insured, with
return receipt requested, and that a sufficient number of days
be allowed to ensure delivery to the subscription agent and
clearance of payment prior to the expiration of the rights
offering.
Unless a rights certificate provides that the shares of our
common stock are to be delivered to the record holder of such
rights or such certificate is submitted for the account of a
bank or a broker, signatures on such rights certificate must be
guaranteed by an eligible guarantor institution, as
such term is defined in
Rule 17Ad-15
of the Exchange Act, subject to any standards and procedures
adopted by the subscription agent.
Missing
or Incomplete Subscription Information
If you do not indicate the number of subscription rights being
exercised, or the subscription agent does not receive the full
subscription payment for the number of subscription rights that
you indicate are being exercised, then you will be deemed to
have exercised the maximum number of subscription rights that
may be exercised with the aggregate subscription payment you
delivered to the subscription agent. If we do not apply your
full subscription payment to your purchase of shares of our
common stock, any excess subscription payment received by the
subscription agent will be returned, without interest, as soon
as practicable.
S-18
Expiration
Date and Amendments
The subscription period, during which you may exercise your
subscription rights, expires at 5:00 p.m., New York City
time, on September 28, 2007, which is the expiration of the
rights offering. If you do not exercise your subscription rights
prior to that time, your subscription rights will expire and
will no longer be exercisable. We will not be required to issue
shares of our common stock to you if the subscription agent
receives your rights certificate or your subscription payment
after that time, regardless of when the rights certificate and
subscription payment were sent, unless you send the documents in
compliance with the guaranteed delivery procedures described
below. We have the option, with the approval of the standby
purchasers, to extend the rights offering and the period for
exercising your subscription rights for a period not to exceed
15 days, although we do not presently intend to do so. We
may extend the expiration of the rights offering by giving oral
or written notice to the subscription agent prior to the
expiration of the rights offering. If we elect to extend the
expiration of the rights offering, we will issue a press release
announcing such extension no later than 9:00 a.m., New York
City time, on the next business day after the most recently
announced expiration of the rights offering. We reserve the
right to amend or modify the terms of the rights offering.
Subscription
Price
Our board of directors determined the terms of the rights
offering and the transactions contemplated by the standby
purchase agreement after negotiations among the parties to the
standby purchase agreement. In determining the subscription
price, our board of directors considered a number of factors,
including: the likely cost of capital from other sources, the
price at which our stockholders might be willing to participate
in the rights offering, historical and current trading prices
for our common stock, our need for liquidity and capital and the
desire to provide an opportunity to our stockholders to
participate in the rights offering on a pro rata basis. In
conjunction with its review of these factors, our board of
directors also reviewed a range of discounts to market value
represented by the subscription prices in various prior rights
offerings of public companies. The subscription price for a
subscription right is $6.55 per full share. The
subscription price is not necessarily related to our book value,
net worth or any other established criteria of value and may or
may not be considered the fair value of our common stock to be
offered in the rights offering.
We cannot assure you that the market price of our common stock
will not decline during or after the rights offering. We also
cannot assure you that you will be able to sell shares of our
common stock purchased during the rights offering at a price
equal to or greater than the subscription price. We urge you to
obtain a current quote for our common stock before exercising
your subscription rights.
Conditions,
Withdrawal and Termination
We reserve the right to withdraw the rights offering prior to
the expiration of the rights offering for any reason. We may
terminate the rights offering, in whole or in part, if at any
time before completion of the rights offering there is any
judgment, order, decree, injunction, statute, law or regulation
entered, enacted, amended or held to be applicable to the rights
offering that in the sole judgment of our board of directors
would or might make the rights offering or its completion,
whether in whole or in part, illegal or otherwise restrict or
prohibit completion of the rights offering. We may waive any of
these conditions and choose to proceed with the rights offering
even if one or more of these events occur. If we terminate the
rights offering, in whole or in part, all affected subscription
rights will expire without value, and all excess subscription
payments received by the subscription agent will be returned,
without interest, as soon as practicable.
Cancellation
Rights
Our board of directors may cancel the rights offering at any
time prior to the time the rights offering expires for any
reason. If we cancel the rights offering, we will issue a press
release notifying stockholders of the cancellation and all
subscription payments received by the subscription agent will be
returned, without interest, as soon as practicable.
S-19
Subscription
Agent
The subscription agent for this offering is American Stock
Transfer & Trust Company. The address to which
subscription documents, rights certificates, notices of
guaranteed delivery and subscription payments other than wire
transfers should be mailed or delivered is:
|
|
|
By Mail or Overnight
Courier:
American Stock
Transfer & Trust Company
Operations Center
Attn: Reorganization Department
6201 15th Avenue
Brooklyn, New York 11219
|
|
By Hand:
American Stock Transfer
& Trust Company
Attn: Reorganization Department
59 Maiden Lane
New York, New York 10038
|
If you deliver subscription documents, rights certificates or
notices of guaranteed delivery in a manner different than that
described in this prospectus supplement, then we may not honor
the exercise of your subscription rights.
You should direct any questions or requests for assistance
concerning the method of subscribing for the shares of our
common stock or for additional copies of this prospectus
supplement and the accompany prospectus to the information
agent, Georgeson Inc., at
(888) 605-7606
or (212) 440-9800 for banks and brokerage firms.
Fees and
Expenses
We will pay all fees charged by the subscription agent and the
information agent. You are responsible for paying any other
commissions, fees, taxes or other expenses incurred in
connection with the exercise of the subscription rights.
No
Fractional Shares
We will not issue fractional shares or cash in lieu of
fractional shares. Fractional shares of our common stock
resulting from the exercise of the basic subscription privileges
and the over-subscription privileges will be eliminated by
rounding down to the nearest whole share, with the total
subscription payment being adjusted accordingly. Any excess
subscription payments received by the subscription agent will be
returned, without interest, as soon as practicable.
Medallion
Guarantee May Be Required
Your signature on each subscription rights certificate must be
guaranteed by an eligible institution, such as a member firm of
a registered national securities exchange or a member of the
National Association of Securities Dealers, Inc., or a
commercial bank or trust company having an office or
correspondent in the United States, subject to standards and
procedures adopted by the subscription agent, unless:
|
|
|
|
|
your subscription rights certificate provides that shares are to
be delivered to you as record holder of those subscription
rights; or
|
|
|
|
you are an eligible institution.
|
Notice To
Nominees
If you are a broker, custodian bank or other nominee holder that
holds shares of our common stock for the account of others on
the record date, you should notify the beneficial owners of the
shares for whom you are the nominee of the rights offering as
soon as possible to learn their intentions with respect to
exercising their subscription rights. You should obtain
instructions from the beneficial owner, as set forth in the
instructions we have provided to you for your distribution to
beneficial owners. If the beneficial owner so instructs, you
should complete the appropriate rights certificate and submit it
to the subscription agent with the proper subscription payment.
If you hold shares of our common stock for the account(s) of
more than one beneficial owner, you may exercise the number of
subscription rights to which all beneficial owners in the
S-20
aggregate otherwise would have been entitled had they been
direct holders of our common stock on the record date, provided
that you, as a nominee record holder, make a proper showing to
the subscription agent by submitting the form entitled
Nominee Holder Certification, which is provided with
your rights offering materials. If you did not receive this
form, you should contact the subscription agent to request a
copy.
Beneficial
Owners
If you are a beneficial owner of shares of our common stock or
will receive your subscription rights through a broker,
custodian bank or other nominee, we will ask your broker,
custodian bank or other nominee to notify you of the rights
offering. If you wish to exercise your subscription rights, you
will need to have your broker, custodian bank or other nominee
act for you. If you hold certificates of our common stock
directly and would prefer to have your broker, custodian bank or
other nominee act for you, you should contact your nominee and
request it to effect the transactions for you. To indicate your
decision with respect to your subscription rights, you should
complete and return to your broker, custodian bank or other
nominee the form entitled Beneficial Owners Election
Form. You should receive this form from your broker,
custodian bank or other nominee with the other rights offering
materials. If you wish to obtain a separate subscription rights
certificate, you should contact the nominee as soon as possible
and request that a separate subscription rights certificate be
issued to you. You should contact your broker, custodian bank or
other nominee if you do not receive this form, but you believe
you are entitled to participate in the rights offering. We are
not responsible if you do not receive the form from your broker,
custodian bank or nominee or if you receive it without
sufficient time to respond.
Guaranteed
Delivery Procedures
If you wish to exercise subscription rights, but you do not have
sufficient time to deliver the rights certificate evidencing
your subscription rights to the subscription agent prior to the
expiration of the rights offering, you may exercise your
subscription rights by the following guaranteed delivery
procedures:
|
|
|
|
|
deliver to the subscription agent prior to the expiration of the
rights offering the subscription payment for each share you
elected to purchase pursuant to the exercise of subscription
rights in the manner set forth above under
Payment Method;
|
|
|
|
deliver to the subscription agent prior to the expiration of the
rights offering the form entitled Notice of Guaranteed
Delivery; and
|
|
|
|
deliver the properly completed rights certificate evidencing
your subscription rights being exercised and the related nominee
holder certification, if applicable, with any required
signatures guaranteed, to the subscription agent within three
(3) business days following the date you submit your Notice
of Guaranteed Delivery.
|
Your Notice of Guaranteed Delivery must be delivered in
substantially the same form provided with the Form of
Instructions as to Use of Exide Technologies Rights
Certificates, which will be distributed to you with your
rights certificate. Your Notice of Guaranteed Delivery must
include a signature guarantee from an eligible institution,
acceptable to the subscription agent. A form of that guarantee
is included with the Notice of Guaranteed Delivery.
In your Notice of Guaranteed Delivery, you must provide:
|
|
|
|
|
your name;
|
|
|
|
the number of subscription rights represented by your rights
certificate, the number of shares of our common stock for which
you are subscribing under your basic subscription privilege, and
the number of shares of our common stock for which you are
subscribing under your over-subscription privilege, if
any; and
|
|
|
|
your guarantee that you will deliver to the subscription agent a
rights certificate evidencing the subscription rights you are
exercising within three (3) business days following the
date the subscription agent receives your Notice of Guaranteed
Delivery.
|
S-21
You may deliver your Notice of Guaranteed Delivery to the
subscription agent in the same manner as your rights certificate
at the address set forth above under
Subscription Agent. You may
alternatively transmit your Notice of Guaranteed Delivery to the
rights agent by facsimile transmission at
(718) 234-5001.
To confirm facsimile deliveries, you may call
(877) 248-6417.
The information agent will send you additional copies of the
form of Notice of Guaranteed Delivery if you need them. Banks
and brokerage firms should call Georgeson Inc. at (212) 440-9800
to request additional copies of the form of Notice of Guaranteed
Delivery. All other persons should call toll-free at
(888) 605-7606.
Transferability
of Subscription Rights
The subscription rights granted to you are non-transferable and,
therefore, you may not sell, transfer or assign your
subscription rights to anyone.
Validity
of Subscriptions
We will resolve all questions regarding the validity and form of
the exercise of your subscription rights, including time of
receipt and eligibility to participate in the rights offering.
Our determination will be final and binding. Once made,
subscriptions and directions are irrevocable, and we will not
accept any alternative, conditional or contingent subscriptions
or directions. We reserve the absolute right to reject any
subscriptions or directions not properly submitted or the
acceptance of which would be unlawful. You must resolve any
irregularities in connection with your subscriptions before the
subscription period expires, unless waived by us in our sole
discretion. Neither we nor the subscription agent shall be under
any duty to notify you or your representative of defects in your
subscriptions. A subscription will be considered accepted,
subject to our right to withdraw or terminate the rights
offering, only when a properly completed and duly executed
rights certificate and any other required documents and the full
subscription payment have been received by the subscription
agent. Our interpretations of the terms and conditions of the
rights offering will be final and binding.
Escrow
Arrangements; Return of Funds
The subscription agent will hold funds received in payment for
shares of our common stock in a segregated account pending
completion of the rights offering. The subscription agent will
hold this money in escrow until the rights offering is completed
or is withdrawn and canceled. If the rights offering is canceled
for any reason, all subscription payments received by the
subscription agent will be returned, without interest, as soon
as practicable.
Stockholder
Rights
You will have no rights as a holder of the shares of our common
stock you purchase in the rights offering, if any, until
certificates representing the shares of our common stock are
issued to you. You will have no right to revoke your
subscriptions after you deliver your completed rights
certificate, the full subscription payment and any other
required documents to the subscription agent.
Foreign
Stockholders
We will not mail this prospectus supplement or rights
certificates to stockholders with addresses that are outside the
United States or that have an army post office or foreign post
office address. The subscription agent will hold these rights
certificates for their account. To exercise subscription rights,
our foreign stockholders must notify the subscription agent
prior to 11:00 a.m., New York City time, at least three
business days prior to the expiration of the rights offering and
demonstrate to the satisfaction of the subscription agent that
the exercise of such subscription rights does not violate the
laws of the jurisdiction of such stockholder.
S-22
No
Revocation or Change
Once you submit the form of rights certificate to exercise any
subscription rights, you are not allowed to revoke or change the
exercise or request a refund of monies paid. All exercises of
subscription rights are irrevocable, even if you learn
information about us that you consider to be unfavorable. You
should not exercise your subscription rights unless you are
certain that you wish to purchase additional shares of our
common stock at the subscription price.
Regulatory
Limitation
We will not be required to issue to you shares of our common
stock pursuant to the rights offering if, in our opinion, you
are required to obtain prior clearance or approval from any
state or federal regulatory authorities to own or control such
shares and if, at the time the rights offering expires, you have
not obtained such clearance or approval.
U.S.
Federal Income Tax Treatment of Rights Distribution
We believe that our distribution and any stockholders
exercise of these subscription rights to purchase shares of our
common stock will not be taxable to our stockholders for the
reasons described below in U.S. Federal Income Tax
Consequences. For a discussion of the tax consequences to
stockholders that receive or exercise the rights if the Internal
Revenue Service determines that these subscription rights have
value, please see U.S. Federal Income Tax
Consequences Receipt, Exercise and Expiration of the
Subscription Rights; Tax Basis and Holding Period of Shares
Received upon Exercise of the Subscription Rights.
Anti-Dilution
Adjustments
The conversion price of our convertible notes will be adjusted
if we issue (other than pursuant to a stockholders rights plan)
to all holders of our common stock or our preferred stock,
rights, warrants or options entitling them to subscribe for or
purchase shares of our common stock at less than the then
current market price. Accordingly, upon the commencement of the
rights offering described herein, the conversion price of our
convertible notes will be reduced from $16.42 to
$
per share.
In addition, if we issue or sell or are deemed to issue or sell
any common stock (other than excluded stock defined in the
warrant agreement) without consideration or for consideration
per share less than the market price (as defined in
the warrant agreement) of our common stock as of the day of such
issuance or sale, the exercise price of our warrants in effect
immediately prior to each such issuance will be reduced and the
number of shares issuable on the exercise of each warrant will
be increased as determined in accordance with a weighted average
formula in the warrant agreement. Accordingly, upon the
commencement of the rights offering described herein, the
exercise price of our warrants will be reduced from $30.31 to
$ per share.
No
Recommendation to Rights Holders
Our board of directors is making no recommendation regarding
your exercise of the subscription rights. You are urged to make
your decision based on your own assessment of our business and
the rights offering. Please see Risk Factors for a
discussion of some of the risks involved in investing in our
common stock.
Listing
The subscription rights will not be listed for trading on The
NASDAQ Global Market or any stock exchange or market or on the
OTC Bulletin Board. The shares of our common stock issuable
upon exercise of the subscription rights will be listed on The
NASDAQ Global Market under the symbol XIDE.
S-23
Shares of
Our Common Stock Outstanding After the Rights Offering
Assuming no options, warrants or convertible notes are exercised
prior to the expiration of the rights offering, we expect
approximately 75,266,314 shares of our common stock will be
outstanding immediately after completion of the rights offering
and the closing of the transactions contemplated by the standby
purchase agreement.
However, as a result of the contractual 49.9% ownership
limitation applicable to the standby purchasers, if no
stockholders other than the standby purchasers exercise their
subscription rights, we expect approximately
71,177,789 shares of our common stock will be outstanding
immediately after completion of the rights offering and the
closing of the transactions contemplated by the standby purchase
agreement.
S-24
U.S.
FEDERAL INCOME TAX CONSEQUENCES
The following discussion is a summary of the material federal
income tax consequences to U.S. Holders (as defined below)
of the receipt of subscription rights in the rights offering and
the ownership, exercise and disposition of the subscription
rights and constitutes the opinion of Jones Day insofar as it
relates to matters of United States federal income tax law and
legal conclusions with respect thereto. In the following
discussion, we, us and similar words
refer to Exide Technologies and not to Jones Day. This
discussion is a summary and does not consider all aspects of
U.S. federal income taxation that may be relevant to
particular U.S. Holders in the light of their individual
investment circumstances or to certain types of
U.S. Holders that are subject to special tax rules,
including partnerships, banks, financial institutions or other
financial services entities, broker-dealers,
insurance companies, tax-exempt organizations, regulated
investment companies, real estate investment trusts, retirement
plans, individual retirement accounts or other tax-deferred
accounts, persons who use or are required to use mark-to-market
accounting, persons that received our common stock in
satisfaction of our prior indebtedness to such persons, persons
that hold rights or our common stock as part of a
straddle, a hedge or a conversion
transaction, persons that have a functional currency other
than the U.S. dollar, investors in pass-through entities,
certain former citizens or permanent residents of the United
States and persons subject to the alternative minimum tax. This
discussion also does not address any federal non-income, state,
local or foreign tax considerations to U.S. Holders, nor
does it address any tax considerations to persons other than
U.S. Holders. This summary assumes that U.S. Holders
have held our common stock exclusively as a capital
asset within the meaning of Section 1221 of the
Internal Revenue Code of 1986, as amended, or the Code. This
summary is based on the Code and applicable Treasury
Regulations, rulings, administrative pronouncements and
decisions as of the date hereof, all of which are subject to
change or differing interpretations at any time with possible
retroactive effect.
For purposes of this discussion, a U.S. Holder
is a beneficial owner of our common stock that is (1) a
citizen or an individual resident of the United States;
(2) a corporation (or entity treated as a corporation for
U.S. federal income tax purposes) created or organized, or
treated as created or organized, in or under the laws of the
United States or any political subdivision of the United States;
(3) an estate the income of which is subject to
U.S. federal income taxation regardless of its source; or
(4) a trust (a) if a court within the United States is
able to exercise primary supervision over its administration and
one or more U.S. persons have authority to control all
substantial decisions of the trust or (b) that has a valid
election in effect under applicable Treasury Regulations to be
treated as a U.S. person.
If a partnership (or entity or arrangement treated as a
partnership for U.S. federal income tax purposes) holds our
common stock, the tax treatment of a partner in the partnership
will depend upon the status of the partner and the activities of
the partnership. In this event, the partner and partnership
should consult their tax advisors concerning the tax treatment
of the receipt of subscription rights in the rights offering and
the ownership, exercise and disposition of the subscription
rights.
EACH HOLDER OF OUR COMMON STOCK IS URGED TO CONSULT ITS TAX
ADVISOR REGARDING THE SPECIFIC FEDERAL, STATE, LOCAL AND FOREIGN
INCOME AND OTHER TAX CONSIDERATIONS OF THE RECEIPT OF
SUBSCRIPTION RIGHTS IN THE RIGHTS OFFERING AND THE OWNERSHIP,
EXERCISE AND DISPOSITION OF THE SUBSCRIPTION RIGHTS.
Receipt, Exercise and Expiration of the Subscription Rights;
Tax Basis and Holding Period of Shares Received upon Exercise of
the Subscription Rights
Receipt
of the Subscription Rights
Provided that the rights offering is not part of a
disproportionate distribution within the meaning of
section 305 of the Code, you will not recognize taxable
income for United States federal income tax purposes in
connection with the receipt of subscription rights in the rights
offering. A disproportionate distribution is a distribution or a
series of distributions, including deemed distributions, that
has the effect of the receipt of cash or other property by some
stockholders or holders of debt instruments convertible into
stock and an increase in the proportionate interest of other
stockholders in a companys assets or earnings and profits.
Although we have made no distributions on our common stock
within the last 36 months (other than
S-25
distributions that qualify as redemptions under the tax law),
because we have outstanding notes convertible into our common
stock and on which we have paid interest, applicable Treasury
regulations provide that the receipt of the subscription rights
will be part of a disproportionate distribution unless a
full adjustment is made in the conversion price of
the notes to reflect the rights offering. The indenture pursuant
to which the convertible notes were issued requires an
adjustment to the conversion price as a result of the rights
offering, and we intend to make this adjustment. The Treasury
regulations do not directly address the adjustment mechanism
contained in the indenture pursuant to which the convertible
notes were issued. Thus, it is uncertain whether the adjustment
to the conversion price required by the indenture qualifies as a
full adjustment, and accordingly it is uncertain
whether the receipt of the subscription rights in the rights
offering would be considered part of a disproportionate
distribution. The fact that we also have outstanding options and
warrants could cause the receipt of subscription rights pursuant
to the rights offering to be part of a disproportionate
distribution. We intend to take the position that the adjustment
to the conversion price required by the indenture qualifies as a
full adjustment and that the outstanding warrants
and options do not cause the subscription rights issued pursuant
to the rights offering to be part of a disproportionate
distribution. If this position is correct, as is assumed for the
remainder of this summary, then the receipt of the subscription
rights in the rights offering will not be taxable. See
Consequences if the Rights Offering is
Considered Part of a Disproportionate Distribution for a
discussion of the tax consequences in the event it is determined
that the rights offering is part of a disproportionate
distribution.
Tax
Basis in the Subscription Rights
If the fair market value of the subscription rights on the date
on which they are distributed equals or exceeds 15% of the fair
market value of our common stock on that date, your basis in the
subscription rights will equal the product of your basis in our
common stock with respect to which you receive the subscription
rights and a fraction, the numerator of which is the fair market
value of a subscription right and the denominator of which is
the fair market value of a share of our common stock plus the
fair market value of a subscription right, all on the date the
subscription rights are distributed. The fair market value of
the subscription rights on the date the subscription rights are
distributed is uncertain, and we have not obtained, and do not
intend to obtain, an appraisal of the fair market value of the
subscription rights on that date. In determining the fair market
value of the subscription rights, you should consider all
relevant facts and circumstances, including any difference
between the $6.55 per full share subscription price of the
subscription rights and the trading price of our common stock on
the date that the subscription rights are distributed, the
length of the period during which the subscription rights may be
exercised and the fact that the subscription rights are
non-transferable.
If the fair market value of the subscription rights on the date
on which they are distributed is less than 15% of the fair
market value of our common stock on that date, your basis in the
subscription rights will be zero unless you elect to allocate
basis using the formula described in the previous sentence. This
election is irrevocable if made and would apply to all of the
subscription rights you receive pursuant to the rights offering.
Exercise
and Expiration of the Subscription Rights
You will not recognize any gain or loss upon the exercise of
subscription rights received in the rights offering, and the tax
basis of the shares of our common stock acquired through
exercise of the subscription rights will equal the sum of the
subscription price for the shares and your tax basis, if any, in
the subscription rights. The holding period for the shares of
our common stock acquired through exercise of the subscription
rights will begin on the date the subscription rights are
exercised.
If you allow subscription rights received in the rights offering
to expire, you will not recognize any gain or loss upon the
expiration of the subscription rights. If you have tax basis in
the subscription rights and you allow the subscription rights to
expire, the tax basis of our common stock owned by you with
respect to which such subscription rights were distributed will
be restored to the tax basis of such common stock immediately
before the receipt of the subscription rights in the rights
offering.
S-26
Consequences
if the Rights Offering is Considered Part of a Disproportionate
Distribution
If the rights offering is part of a disproportionate
distribution, the distribution of subscription rights would be
taxable to you as a dividend to the extent that the fair market
value of the subscription rights you receive is allocable to our
current and accumulated earnings and profits for the taxable
year in which the subscription rights are distributed. We
believe that we do not have any accumulated earnings and
profits, and, although it is not possible to determine our
current earnings and profits for the taxable year that includes
the date of the subscription rights distribution, we expect that
we will not have current earnings and profits for that taxable
year. Dividends received by corporate holders of our common
stock are taxable at ordinary corporate tax rates subject to any
applicable dividends-received deduction. Dividends received by
noncorporate holders of our common stock in taxable years
beginning before January 1, 2011 are taxed under current
law at the holders capital gain tax rate (a maximum rate
of 15 percent) provided that the holder meets applicable
holding period and other requirements. Any distributions in
excess of our current and accumulated earnings and profits will
be treated as a tax-free return of basis, and any further
distributions in excess of your basis in our common stock will
be treated as gain from the sale or exchange of our common stock
(unless, as discussed in more detail below, you received our
common stock with respect to which the subscription rights were
distributed in satisfaction of our prior indebtedness to you).
Regardless of whether the distribution of subscription rights is
treated as a dividend, as a tax-free return of basis or as gain
from the sale or exchange of our common stock, your basis in the
subscription rights you receive will be the subscription
rights fair market value.
If the receipt of subscription rights is taxable as described in
the previous paragraph and if you allow subscription rights
received in the rights offering to expire, you should recognize
a short-term capital loss equal to your basis in the expired
subscription rights. Your ability to use any capital loss is
subject to certain limitations. You will not recognize any gain
or loss upon the exercise of the subscription rights, and the
tax basis of the shares of our common stock acquired through
exercise of the subscription rights will equal the sum of the
subscription price for the shares and your tax basis in the
subscription rights. The holding period for the shares of our
common stock acquired through exercise of the subscription
rights will begin on the date the subscription rights are
exercised.
Sale of
Shares of Our Common Stock and Receipt of Distributions on
Shares of Our Common Stock
You will recognize capital gain or loss upon the sale of our
common stock acquired through the exercise of subscription
rights in an amount equal to the difference between the amount
realized and your tax basis in our common stock (unless, as
discussed in more detail below, you received our common stock
with respect to which the subscription rights were distributed
in satisfaction of our prior indebtedness to you). The capital
gain or loss will be long-term if your holding period in the
shares is more than one year. Long-term capital gains recognized
by individuals are taxable under current law at a maximum rate
of 15 percent. Under current law, long-term capital gains
recognized by individuals will be taxable at a maximum rate of
20 percent for taxable years beginning after
December 31, 2010. Long-term capital gains recognized by
corporations are taxable at ordinary corporate tax rates. If you
have held your shares of our common stock for one year or less,
your capital gain or loss will be short-term. Short-term capital
gains are taxed at a maximum rate equal to the maximum rate
applicable to ordinary income. Your ability to use any capital
loss is subject to certain limitations.
Distributions, if any, on shares of our common stock acquired
through the exercise of subscription rights will be taxable to
you as a dividend to the extent that the cash and fair market
value of property is allocable to our current and accumulated
earnings and profits for the taxable year in which the
distribution is made. Dividends received by corporate holders of
our common stock are taxable at ordinary corporate tax rates
subject to any applicable dividends-received deduction.
Dividends received by noncorporate holders of our common stock
in taxable years beginning before January 1, 2011 are taxed
under current law at the holders capital gain tax rate (a
maximum rate of 15 percent) provided that the holder meets
applicable holding period and other requirements. Under current
law, dividends received by noncorporate holders of our common
stock in subsequent taxable years will be taxed as ordinary
income at a maximum rate of 35 percent. Any distributions
in excess of our current and accumulated earnings and profits
will be treated as a tax-free return of basis, and any further
distributions in excess of your basis in our common stock will
be treated as gain
S-27
from the sale or exchange of such common stock (unless, as
discussed in more detail below, you received our common stock
with respect to which the subscription rights were distributed
in satisfaction of our prior indebtedness to you). Your basis in
any property you receive as a distribution on shares of our
common stock will be the propertys fair market value
(regardless of whether the distribution is treated as a
dividend, as a tax-free return of basis or as gain from the sale
or exchange of our common stock).
Finally, note that if you received our common stock with respect
to which the subscription rights were distributed in
satisfaction of our prior indebtedness to you, then you may be
required to treat a portion of your gain from the sale or
exchange of our common stock you acquire through the exercise of
the subscription rights as ordinary income to the extent that
you previously recognized an ordinary loss on your receipt of
our common stock in exchange for the prior indebtedness or to
the extent you previously recognized deductions due to the full
or partial worthlessness of that prior indebtedness. In
addition, you may be subject to special rules if you engage in a
transaction with respect to our common stock you acquire through
the exercise of the subscription rights that generally would be
tax-free or permit deferral of gain or income recognition. If
you received our common stock with respect to which the
subscription rights were distributed in satisfaction of our
prior indebtedness to you, you are urged to consult your own tax
advisor concerning these issues.
Information
Reporting and Backup Withholding
You may be subject to information reporting
and/or
backup withholding with respect to dividend payments on or the
gross proceeds from the disposition of our common stock acquired
through the exercise of subscription rights. Backup withholding
may apply under certain circumstances if you (1) fail to
furnish your social security or other taxpayer identification
number, or TIN, (2) furnish an incorrect TIN, (3) fail
to report interest or dividends properly, or (4) fail to
provide a certified statement, signed under penalty of perjury,
that the TIN provided is correct and that you are not subject to
backup withholding. Any amount withheld from a payment under the
backup withholding rules is allowable as a credit against (and
may entitle you to a refund with respect to) your federal income
tax liability, provided that the required information is
furnished to the Internal Revenue Service. Certain persons are
exempt from backup withholding, including corporations and
financial institutions. You should consult your tax advisors as
to your qualification for exemption from withholding and the
procedure for obtaining such exemption.
S-28
Our common stock trades on The NASDAQ Global Market under the
trading symbol XIDE. On
August , 2007, there were
record holders of our common stock. This number does not
include the number of persons or entities that hold stock in
nominee or street name through various brokerage firms, banks
and other nominees. On August 27, 2007, the last closing
sale price reported on The NASDAQ Global Market for our common
stock was $7.02 per share.
The following table sets forth the high and low sale prices of
our common stock on The NASDAQ Global Market:
|
|
|
|
|
|
|
|
|
|
|
Price Range
|
|
|
|
High
|
|
|
Low
|
|
|
Fiscal 2006
|
|
|
|
|
|
|
|
|
First Quarter
|
|
$
|
13.51
|
|
|
$
|
4.20
|
|
Second Quarter
|
|
$
|
5.99
|
|
|
$
|
4.18
|
|
Third Quarter
|
|
$
|
5.18
|
|
|
$
|
3.37
|
|
Fourth Quarter
|
|
$
|
4.34
|
|
|
$
|
2.35
|
|
Fiscal 2007
|
|
|
|
|
|
|
|
|
First Quarter
|
|
$
|
5.07
|
|
|
$
|
2.71
|
|
Second Quarter
|
|
$
|
4.81
|
|
|
$
|
3.42
|
|
Third Quarter
|
|
$
|
4.84
|
|
|
$
|
3.57
|
|
Fourth Quarter
|
|
$
|
9.29
|
|
|
$
|
4.36
|
|
Fiscal 2008
|
|
|
|
|
|
|
|
|
First Quarter
|
|
$
|
9.79
|
|
|
$
|
7.06
|
|
Second Quarter (through
August 27, 2007)
|
|
$
|
10.05
|
|
|
$
|
6.24
|
|
We have not declared or paid dividends on our common stock
during fiscal years 2006, 2007 and 2008. Covenants in our senior
secured credit agreement restrict our ability to pay cash
dividends on capital stock and we presently do not intend to pay
dividends on our common stock.
As soon as practicable after the record date for the rights
offering, we will distribute the subscription rights and rights
certificates to individuals who owned shares of our common stock
at 5:00 p.m., New York City time, on August 30, 2007.
If you wish to exercise your subscription rights and purchase
shares of our common stock, you should complete the rights
certificate and return it with payment for the shares to the
subscription agent, American Stock Transfer &
Trust Company, at the following address:
|
|
|
By Mail or Overnight
Courier:
American Stock
Transfer & Trust Company
Operations Center
Attn: Reorganization Department
6201 15th Avenue
Brooklyn, New York 11219
|
|
By Hand:
American Stock Transfer
& Trust Company
Attn: Reorganization Department
59 Maiden Lane
New York, New York 10038
|
See The Rights Offering Method of Exercising
Subscription Rights. If you have any questions, you should
contact the information agent, Georgeson Inc., at
(888) 605-7606
or (212) 440-9800 for banks and brokerage firms.
S-29
Other than the standby purchase agreement as described herein,
we do not know of any existing agreements between or among any
stockholder, broker, dealer, underwriter or agent relating to
the sale or distribution of the underlying common stock.
Jones Day, Chicago, Illinois, will render an opinion regarding
whether the shares of common stock into which the rights are
exercisable will be validly issued. Richards, Layton &
Finger, PA, Wilmington, Delaware, will render an opinion
regarding whether the rights offered in the rights offering are
our binding obligations. Material U.S. federal income tax
consequences of the rights offering also will be passed upon by
Jones Day, Chicago, Illinois.
The financial statements and managements assessment of the
effectiveness of internal control over financial reporting
(which is included in Managements Report on Internal
Control Over Financial Reporting) incorporated in this
prospectus supplement by reference to the Annual Report on
Form 10-K
for the year ended March 31, 2007 have been so incorporated
in reliance on the report of PricewaterhouseCoopers LLP, an
independent registered public accounting firm, given on the
authority of said firm as experts in auditing and accounting.
INCORPORATION
BY REFERENCE
The SEC allows us to incorporate by reference information
contained in documents we file with it, which means that we can
disclose important information to you by referring you to those
documents already on file with the SEC that contain that
information. The information incorporated by reference is
considered to be part of this prospectus supplement and the
accompanying prospectus. The following documents, which have
been filed with the SEC pursuant to the Exchange Act, are
incorporated by reference:
|
|
|
|
|
our Annual Report on
Form 10-K
for the fiscal year ended March 31, 2007;
|
|
|
|
our Quarterly Report on
Form 10-Q
for the fiscal quarter ended June 30, 2007; and
|
|
|
|
our Current Reports on
Form 8-K,
filed with the SEC on June 12, 2007 (other than Item
2.02), August 24, 2007 and August 28, 2007.
|
In addition, we also incorporate by reference in this prospectus
supplement and the accompanying prospectus all documents that we
file with the SEC during the rights offering subscription period
pursuant to Sections 13(a), 13(c), 14 or 15(d) of the
Exchange Act, including annual reports on
Form 10-K,
quarterly reports on
Form 10-Q
and current reports on
Form 8-K.
The information contained in these future filings will
automatically update and supersede the information contained in
this prospectus supplement and the accompanying prospectus or
incorporated by reference to any previously filed document.
You may request copies of the documents incorporated by
reference in this prospectus supplement and the accompanying
prospectus, at no cost, by writing or telephoning us at:
Exide Technologies
13000 Deerfield Parkway
Building 200
Alpharetta, Georgia 30004
(678) 566-9000
Attention: Corporate Secretary
S-30
PROSPECTUS
Common
Stock
Preferred Stock
Rights
Warrants
Depositary Shares
Purchase Contracts
Units
Debt Securities
$500,000,000
We may offer and sell from time to time, in one or more
offerings, together or separately, any combination of the
securities described in this prospectus. Such securities may be
offered and sold by us in one or more offerings with a total
aggregate principal amount or initial purchase price not to
exceed $500,000,000. This prospectus describes some of the
general terms that may apply to these securities. The specific
terms of any securities to be offered will be described in a
supplement to this prospectus and may be further described in a
post-effective amendment to the registration statement of which
this prospectus is a part, in a supplement to this prospectus or
in any other offering material related to the securities.
We may offer and sell these securities to or through one or more
underwriters, dealers or agents, or directly to purchasers, on a
continuous or delayed basis. Each prospectus supplement will
provide the names of the underwriters, dealers or agents, if
any, and the amount, price and terms of the plan of distribution
relating to the securities to be offered pursuant to such
prospectus supplement, as well as the net proceeds we expect to
receive from such sale.
You should carefully consider the risk factors set forth in
the applicable prospectus supplement and certain of our filings
with the Securities and Exchange Commission, as described under
the section entitled Risk Factors on page 2 of
this prospectus, before making any decision to invest in any of
the securities described in this prospectus.
Shares of our common stock are traded on The NASDAQ Global
Market under the symbol XIDE. On March 29,
2007, the last reported sales price for our common stock was
$8.65 per share.
You should read this prospectus, the applicable prospectus
supplement and the documents incorporated by reference in this
prospectus and any prospectus supplement carefully before you
invest in any of these securities. This prospectus may not be
used to sell securities unless accompanied by a prospectus
supplement.
Neither the Securities and Exchange Commission nor any other
regulatory body has approved or disapproved of these securities
or passed upon the adequacy or accuracy of this prospectus. Any
representation to the contrary is a criminal offense.
The date of this prospectus is April 13, 2007.
TABLE OF
CONTENTS
|
|
|
|
|
|
|
Page
|
|
|
|
|
1
|
|
|
|
|
2
|
|
|
|
|
2
|
|
|
|
|
3
|
|
|
|
|
3
|
|
|
|
|
4
|
|
|
|
|
6
|
|
|
|
|
7
|
|
|
|
|
8
|
|
|
|
|
9
|
|
|
|
|
9
|
|
|
|
|
10
|
|
|
|
|
10
|
|
|
|
|
19
|
|
|
|
|
23
|
|
|
|
|
23
|
|
|
|
|
23
|
|
|
|
|
24
|
|
You should rely only on the information contained in or
incorporated by reference in this prospectus. We have not
authorized anyone to provide you with additional or different
information from that contained or incorporated by reference in
this prospectus. The information contained in this prospectus is
accurate only as of the date on the front cover of this
prospectus, and any information we have incorporated by
reference in this prospectus is accurate only as of the date of
the document incorporated by reference, regardless of the time
of delivery of this prospectus or the securities offered hereby.
We are not making an offer to sell these securities in any
jurisdiction where the offer or sale is not permitted.
As permitted under the rules of the Securities and Exchange
Commission, or SEC, this prospectus incorporates important
business information about Exide Technologies that is contained
in documents that we file with the SEC, but that are not
included in or delivered with this prospectus. You may obtain
copies of these documents, without charge, from the website
maintained by the SEC at www.sec.gov, as well as other sources.
See Where You Can Find Additional Information.
i
ABOUT
THIS PROSPECTUS
This prospectus is part of a registration statement that we
filed with the SEC using a shelf registration
process. Under this shelf process, we may offer and sell from
time to time, in one or more offerings, together or separately,
any combination of the securities described in this prospectus
up to a total aggregate principal amount of $500,000,000.
References in this prospectus to Exide, the
Company, we, us and
our refer to Exide Technologies and its consolidated
subsidiaries.
This prospectus provides you with a general description of the
securities. These summary descriptions are not intended to be
complete descriptions of each security. Each time we offer the
securities, we will provide a prospectus supplement that will
contain specific information about the terms of that offering.
The prospectus supplement may also supplement, modify or
supersede other information contained in this prospectus. You
should read both this prospectus and any applicable prospectus
supplement together with the information described below under
the headings Incorporation by Reference and
Where You Can Find Additional Information.
You should rely only on the information contained in or
incorporated by reference in this prospectus. We have not
authorized anyone to provide you with additional or different
information from that contained or incorporated by reference in
this prospectus. The information contained in this prospectus is
accurate only as of the date on the front cover of this
prospectus, and any information we have incorporated by
reference in this prospectus is accurate only as of the date of
the document incorporated by reference, regardless of the time
of delivery of this prospectus or the securities offered hereby.
We are not making an offer to sell these securities in any
jurisdiction where the offer or sale is not permitted.
1
RISK
FACTORS
An investment in our securities involves a high degree of risk.
Before making an investment decision, you should carefully
consider the risk factors incorporated by reference in this
prospectus, as well as those contained in any applicable
prospectus supplement, as the same may be updated from time to
time by our future filings under the Securities Exchange Act of
1934. You should also refer to the other information contained
in or incorporated by reference in this prospectus and any
applicable prospectus supplement, including our financial
statements and the related notes incorporated by reference
herein. Additional risks and uncertainties not currently known
to us or that we currently deem to be immaterial may also
materially and adversely affect our business and operations.
DISCLOSURE
REGARDING FORWARD-LOOKING STATEMENTS
Some of the statements made and information contained in this
prospectus and the documents we incorporate by reference herein,
excluding historical information, are forward-looking
statements within the meaning of the Private Securities
Litigation Reform Act of 1995. These statements may be found
throughout this prospectus and the documents we incorporate by
reference. Forward-looking statements typically are identified
by the use of terms such as may, will,
should, expect, anticipate,
believe, estimate, intend
and similar words, although some forward-looking statements are
expressed differently and describe our expectations, plans,
strategies and goals and our beliefs concerning future business
conditions, our results of operations, financial position, and
our business outlook or state other forward-looking
information based on currently available information. The
factors listed above under the heading Risk Factors
and in other sections of this prospectus and the documents we
incorporate by reference herein provide examples of risks,
uncertainties and events that could cause our actual results to
differ materially from the expectations expressed in our
forward-looking statements. These statements include, among
other things, the following:
|
|
|
|
|
projections of revenues, cost of raw materials, income or loss,
earnings or loss per share, capital expenditures, growth
prospects, dividends, the effect of currency translations,
capital structure and other financial items;
|
|
|
|
|
|
statements regarding our plans and objectives, including the
introduction of new products or estimates or predictions of
actions by customers, suppliers, competitors or regulating
authorities;
|
|
|
|
statements of future economic performance;
|
|
|
|
statements of assumptions, such as the prevailing weather
conditions in our market areas, underlying other statements and
statements about our business; and
|
|
|
|
statements regarding our ability to obtain amendments under our
debt agreements.
|
Factors that could cause actual results to differ materially
from these forward-looking statements include, but are not
limited to the following general factors:
|
|
|
|
|
our ability to implement and fund our business strategies and
restructuring plans based on current liquidity;
|
|
|
|
lead, which experiences significant fluctuations in market price
and which, as a hazardous material, may give rise to costly
environmental and safety claims, can affect our results because
it is a major constituent in most of our products;
|
|
|
|
|
|
unseasonable weather (warm winters and cool summers), which
adversely affects demand for automotive and some industrial
energy batteries;
|
|
|
|
|
|
our reliance on a single supplier for our polyethylene battery
separators;
|
|
|
|
a pending preliminary SEC inquiry;
|
|
|
|
our substantial debt and debt service requirements which
restrict our operating and financial flexibility, and impose
significant interest and financing costs and our ability to
comply with the covenants in our debt agreements or obtain
waivers of noncompliance;
|
2
|
|
|
|
|
we are subject to a number of litigation and regulatory
proceedings, the results of which could have a material adverse
effect on our business, financial condition or results of
operations;
|
|
|
|
the realization of the tax benefits of our net operating loss
carry forwards, which are dependent upon future taxable income;
|
|
|
|
the battery markets in North America and Europe are very
competitive and, as a result, it is often difficult to maintain
margins;
|
|
|
|
foreign operations involve risk such as disruption of markets,
changes in import and export laws, currency restrictions,
currency exchange rate fluctuations and possible terrorist
attacks against U.S. interests;
|
|
|
|
we are exposed to fluctuations in interest rates on our variable
debt which can affect our results;
|
|
|
|
our ability to maintain and generate liquidity to meet our
operating needs;
|
|
|
|
general economic conditions;
|
|
|
|
Asian batteries sold in North America and Europe at lower prices;
|
|
|
|
our ability to acquire goods and services or fulfill labor needs
at budgeted costs;
|
|
|
|
our ability to attract and retain key personnel;
|
|
|
|
our ability to pass along increased material costs to our
customers;
|
|
|
|
the loss of one or more of our major customers;
|
|
|
|
our significant pension obligations over the next several years;
|
|
|
|
the substantial management time and financial and other
resources needed for our consolidation and rationalization of
acquired entities; and
|
|
|
|
our ability to comply with the provisions of Section 404 of
the Sarbanes-Oxley Act of 2002.
|
Although we believe that the expectations reflected in such
forward-looking statements are reasonable, we can give no
assurance that such expectations will prove to have been
correct. The forward-looking statements made in this prospectus
and the documents we incorporate by reference relate only to
events as of the date on which the statements are made. We
undertake no obligation to update beyond that required by law
any forward-looking statement to reflect events or circumstances
after the date on which the statement is made or to reflect the
occurrence of unanticipated events.
USE OF
PROCEEDS
We intend to use the net proceeds from the sales of the
securities described in this prospectus as set forth in the
applicable prospectus supplement.
RATIOS OF
EARNINGS TO FIXED CHARGES
The deficiency of earnings to fixed charges for each of the
periods indicated is as follows (dollars in thousands):
Deficiency
of Earnings to Fixed Charges
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Predecessor Company
|
|
|
Successor Company
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Fiscal Year
|
|
|
Nine Months
|
|
|
|
|
|
|
|
|
|
Period from
|
|
|
Period from
|
|
|
Ended
|
|
|
Ended
|
|
Fiscal Year Ended
|
|
|
April 1, 2004 to
|
|
|
May 6, 2004 to
|
|
|
March 31,
|
|
|
December 31,
|
|
2002
|
|
2003
|
|
|
2004
|
|
|
May 5, 2004
|
|
|
March 31, 2005
|
|
|
2006
|
|
|
2006
|
|
|
$301,159
|
|
$
|
110,714
|
|
|
$
|
90,109
|
|
|
$
|
40,795
|
(1)
|
|
$
|
449,218
|
|
|
$
|
154,452
|
|
|
$
|
82,570
|
|
|
|
|
(1) |
|
Excludes gain on discharge of liabilities of $1,558,839 and
fresh start accounting adjustments of $228,371. |
3
For purposes of computing the ratios of earnings to fixed
charges, earnings consist of income before provision for fixed
charges, amortization of capitalized interest and unremitted
earnings from equity investments, less interest capitalized and
minority interest. Fixed charges include interest expense,
amortization of deferred financing costs, amortization of
original issue discount on notes and the portion of rental
expense under operating leases deemed by us to be representative
of the interest factor. The ratio of earnings to fixed charges
was less than 1.00x for all periods presented in the table
above. Earnings available for fixed charges were inadequate to
cover fixed charges for such periods by the amounts indicated in
the table.
We have not included a ratio of earnings to combined fixed
charges and preferred stock dividends because, as of the date of
this prospectus, we had no preferred stock outstanding.
DESCRIPTION
OF COMMON STOCK
The following description of our common stock and certain
provisions of our certificate of incorporation and bylaws is a
summary of the material terms thereof and is qualified in its
entirety by the provisions of our certificate of incorporation
and bylaws, copies of which have been filed with the SEC and are
available for inspection. See Where You Can Find
Additional Information.
Common
Stock
As of March 28, 2007, our authorized common stock consisted
of 100,000,000 shares of common stock, $0.01 par value
per share, and 60,675,876 shares of our common stock were
outstanding. In addition, shares of our common stock are
issuable upon the exercise of conversion rights under our
outstanding options, warrants and convertible notes. For more
information regarding these convertible securities, see the
information under the caption Description of Securities
Convertible into Common Stock.
Holders of our common stock are entitled to one vote for each
share held on all matters submitted to a vote of shareholders,
including the election of directors. Accordingly, holders of a
majority of the shares of common stock entitled to vote in any
election of directors may elect all of the directors standing
for election if they choose to do so. Our certificate of
incorporation does not provide for cumulative voting for the
election of directors. Holders of common stock are entitled to
receive ratably such dividends, if any, as may be declared from
time to time by our board of directors out of funds legally
available therefor, and are entitled to receive, pro rata, all
of our assets available for distribution to such holders upon
liquidation. Holders of common stock have no preemptive or
redemption rights. All outstanding shares of our common stock
are fully paid and nonassessable.
The preceding description sets forth certain general terms and
provisions of our common stock and is not complete. We encourage
you to read our certificate of incorporation and bylaws for
additional information before you decide whether to purchase any
shares of our common stock.
Anti-Takeover
Effects of Our Certificate of Incorporation and Bylaws
Some provisions of our certificate of incorporation and bylaws
may be deemed to have an anti-takeover effect and may delay or
prevent a tender offer or takeover attempt that a shareholder
might consider to be in its best interest, including those
attempts that might result in a premium over the market price
for the shares held by shareholders.
These provisions include, but are not limited to:
No
Removal of Directors Without Cause
Directors may be removed by the shareholders only for cause.
Board
Vacancies
Our certificate of incorporation authorizes our board of
directors to fill vacant directorships or to increase the size
of our board of directors, which may deter a shareholder from
removing incumbent directors and
4
simultaneously gaining control of our board of directors by
filling the vacancies created by this removal with its own
nominees.
Cumulative
Voting
Our certificate of incorporation does not authorize our
shareholders the right to cumulative voting in the election of
directors. As a result, shareholders may not aggregate their
votes for a single director.
Shareholder
Action Without a Meeting
Our bylaws prevent our shareholders from taking action without a
meeting called in accordance with the bylaws. As a result, our
shareholders cannot act by written consent.
Advance
Notice of Director Nominees and Other Matters to Come Before
Shareholder Meetings
Our bylaws require shareholders to notify us prior to the date
which is 90 days before the anniversary of the last annual
meeting of shareholders of any nominations they will propose for
directors or other matters they wish to propose at the annual
meeting.
Authorized
but Unissued Shares
Our authorized but unissued shares of common stock and preferred
stock are available for future issuance without shareholder
approval. These additional shares may be utilized for a variety
of corporate purposes, including future public offerings to
raise additional capital, corporate acquisitions and employee
benefit plans. The existence of authorized but unissued shares
of common stock and preferred stock could render more difficult
or discourage an attempt to obtain control of a majority of our
common stock by means of a proxy contest, tender offer, merger
or otherwise.
Section 203
of Delaware General Corporation Law
We are subject to the business combination statute
of the Delaware General Corporation Law. In general, such
statute prohibits a publicly held Delaware corporation from
engaging in various business combination
transactions with any interested shareholder for a
period of three years after the date of the transaction in which
the person became an interested shareholder, unless:
|
|
|
|
|
the transaction is approved by our board of directors prior to
the date the interested shareholder obtained such status;
|
|
|
|
|
|
upon consummation of the transaction which resulted in the
shareholder becoming an interested shareholder, the
interested shareholder owned at least 85% of the
voting stock of the corporation outstanding at the time the
transaction commenced, excluding specified shares; or
|
|
|
|
|
|
on or subsequent to such date the business
combination is approved by our board of directors and
authorized at an annual or special meeting of the shareholders
by the affirmative vote of at least
662/3%
of the outstanding voting stock which is not owned by the
interested shareholder.
|
A business combination includes mergers, asset sales
and other transactions resulting in financial benefit to a
shareholder. An interested shareholder is a person
who, together with affiliates and associates, owns (or within
three years, did own) 15% or more of a corporations voting
stock. The statute could prohibit or delay mergers or other
takeover or change in control attempts with respect to us and,
accordingly, may discourage attempts to acquire us.
Transfer
Agent
American Stock Transfer & Trust Company is the transfer
agent for our common stock.
5
DESCRIPTION
OF PREFERRED STOCK
The following description of our preferred stock and certain
provisions of our certificate of incorporation is a summary of
the material terms thereof and is qualified in its entirety by
the provisions of our certificate of incorporation, copies of
which have been filed with the SEC and are available for
inspection. See Where You Can Find Additional
Information.
Pursuant to our certificate of incorporation, we are authorized
to issue 1,000,000 shares of blank check
preferred stock, $0.01 par value per share, which may be
issued from time to time in one or more series upon
authorization by our Board of Directors. No shares of preferred
stock are issued or outstanding.
Our Board of Directors, without further approval of the
shareholders, is authorized to fix the dividend rights and
terms, conversion rights, voting rights, redemption rights and
terms, liquidation preferences, and any other rights,
preferences, privileges and restrictions applicable to each
series of the preferred stock. The applicable prospectus
supplement will describe the terms of any units in respect of
which this prospectus is being delivered, including, to the
extent applicable, the following:
|
|
|
|
|
the designation of such series;
|
|
|
|
the dividend rate of such series, the conditions and dates upon
which such dividends shall be payable, the relation that such
dividends shall bear to the dividends payable on any other class
or classes or series of our capital stock, and whether such
dividends shall be cumulative or non-cumulative;
|
|
|
|
whether the shares of such series shall be subject to redemption
for cash, property or rights, including our securities or the
securities of any other corporation, by us at either our option
or the option of the holder or both or upon the happening of a
specified event, and, if made subject to any such redemption,
the times or events, prices and other terms and conditions of
such redemption;
|
|
|
|
the terms and amount of any sinking fund provided for the
purchase or redemption of the shares of such series;
|
|
|
|
whether or not the shares of such series shall be convertible
into, or exchangeable for, at the option of either the holder or
us or upon the happening of a specified event, shares of any
other class or classes or of any other series of the same or any
other class or classes of our capital stock, and, if provision
be made for conversion or exchange, the times or events, prices,
rates, adjustments and other terms and conditions of such
conversions or exchanges;
|
|
|
|
the restrictions, if any, on the issue or reissue of any
additional preferred stock;
|
|
|
|
the rights of the holders of the shares of such series upon our
voluntary or involuntary liquidation, dissolution or winding
up; and
|
|
|
|
the provisions as to voting (which may be one or more votes per
share or a fraction of a vote per share), optional or other
special rights and preferences, if any.
|
Delaware law provides that the holders of preferred stock have
the right to vote separately as a class on any proposal
involving fundamental changes in the rights of holders of that
preferred stock. This right is in addition to any voting rights
that may be provided for in the applicable certificate of
designation for preferred stock.
The preceding description sets forth certain general terms and
provisions of the preferred stock to which any prospectus
supplement may relate. The particular terms of the preferred
stock to which any prospectus supplement may relate and the
extent, if any, to which the general provisions may apply to the
preferred stock so offered will be described in the applicable
prospectus supplement. To the extent that any particular terms
of the certificate of designation described in a prospectus
supplement differ from any of the terms described below, then
the terms described below will be deemed to have been superseded
by that prospectus supplement. We encourage you to read the
applicable certificate of designation for additional information
before you decide whether to purchase any of our preferred stock.
6
DESCRIPTION
OF RIGHTS
We may issue rights to our stockholders to purchase shares of
our common stock or our preferred stock. Each series of rights
will be issued under a separate rights agreement to be entered
into between us and a bank or trust company, as rights agent.
The rights agent will act solely as our agent in connection with
the certificates relating to the rights of the series of
certificates and will not assume any obligation or relationship
of agency or trust for or with any holders of rights
certificates or beneficial owners of rights. The following
description sets forth certain general terms and provisions of
the rights to which any prospectus supplement may relate. The
particular terms of the rights to which any prospectus
supplement may relate and the extent, if any, to which the
general provisions may apply to the rights so offered will be
described in the applicable prospectus supplement. To the extent
that any particular terms of the rights, rights agreements or
rights certificates described in a prospectus supplement differ
from any of the terms described below, then the terms described
below will be deemed to have been superseded by that prospectus
supplement. We encourage you to read the applicable rights
agreement and rights certificate for additional information
before you decide whether to purchase any of our rights.
We will provide in a prospectus supplement the following terms
of the rights being issued:
|
|
|
|
|
the date of determining the stockholders entitled to the rights
distribution;
|
|
|
|
the aggregate number of shares of common stock or preferred
stock purchasable upon exercise of the rights;
|
|
|
|
the exercise price;
|
|
|
|
the aggregate number of rights issued;
|
|
|
|
the date, if any, on and after which the rights will be
separately transferable;
|
|
|
|
the date on which the right to exercise the rights will
commence, and the date on which the right will expire;
|
|
|
|
the method by which holders of rights will be entitled to
exercise;
|
|
|
|
the conditions to the completion of the offering, if any;
|
|
|
|
the withdrawal, termination and cancellation rights, if any;
|
|
|
|
any applicable federal income tax considerations; and
|
|
|
|
any other terms of the rights, including terms, procedures and
limitations relating to the distribution, exchange and exercise
of the rights.
|
Each right will entitle the holder of rights to purchase for
cash the principal amount of shares of common stock or preferred
stock at the exercise price provided in the applicable
prospectus supplement. Rights may be exercised at any time up to
the close of business on the expiration date for the rights
provided in the applicable prospectus supplement.
Holders may exercise rights as described in the applicable
prospectus supplement. Upon receipt of payment and the rights
certificate properly completed and duly executed at the
corporate trust office of the rights agent or any other office
indicated in the prospectus supplement, we will, as soon as
practicable, forward the shares of common stock or preferred
stock, as applicable, purchasable upon exercise of the rights.
If less than all of the rights issued in any rights offering are
exercised, we may offer any unsubscribed securities directly to
persons other than stockholders, to or through agents,
underwriters or dealers or through a combination of such
methods, including pursuant to standby arrangements, as
described in the applicable prospectus supplement.
7
DESCRIPTION
OF WARRANTS
We may issue warrants for the purchase of our debt securities,
common stock, preferred stock or depositary shares or any
combination thereof. Warrants may be issued independently or
together with any other securities offered by a prospectus
supplement. Warrants may be attached to or separate from such
securities. Warrants may be issued under warrant agreements to
be entered into between us and a warrant agent specified in the
applicable prospectus supplement. The warrant agent will act
solely as our agent in connection with the warrants of a
particular series and will not assume any obligation or
relationship of agency or trust for or with any holders or
beneficial owners of warrants.
The following description sets forth certain general terms and
provisions of the warrants to which any prospectus supplement
may relate. The particular terms of the warrants to which any
prospectus supplement may relate and the extent, if any, to
which the general provisions may apply to the warrants so
offered will be described in the applicable prospectus
supplement. To the extent that any particular terms of the
warrants, warrant agreements or warrant certificates described
in a prospectus supplement differ from any of the terms
described below, then the terms described below will be deemed
to have been superseded by that prospectus supplement. We
encourage you to read the applicable warrant agreement and
certificate for additional information before you decide whether
to purchase any of our warrants.
The applicable prospectus supplement will describe the terms of
the warrants in respect of which this prospectus is being
delivered, including, where applicable, the following:
|
|
|
|
|
the title of such warrants;
|
|
|
|
the aggregate number of such warrants;
|
|
|
|
the price or prices at which such warrants will be issued;
|
|
|
|
the designation, number and terms of our debt securities, common
stock, preferred stock or depositary shares or combination
thereof, purchasable upon exercise of such warrants;
|
|
|
|
the designation and terms of the other securities, if any, with
which such warrants are issued and the number of such warrants
issued with each such security;
|
|
|
|
the date, if any, on and after which such warrants and the
related underlying securities will be separately transferable;
|
|
|
|
the price at which each underlying security purchasable upon
exercise of such warrants may be purchased;
|
|
|
|
the date on which the right to exercise such warrants shall
commence and the date on which such right shall expire;
|
|
|
|
the minimum amount of such warrants which may be exercised at
any one time;
|
|
|
|
information with respect to book-entry procedures, if any;
|
|
|
|
any applicable federal income tax considerations; and
|
|
|
|
any other terms of such warrants, including terms, procedures
and limitations relating to the transferability, exchange and
exercise of such warrants.
|
Each warrant will entitle the holder of warrants to purchase for
cash the amount of debt or equity securities, at the exercise
price stated or determinable in the prospectus supplement for
the warrants. Warrants may be exercised at any time up to the
close of business on the expiration date shown in the applicable
prospectus supplement, unless otherwise specified in such
prospectus supplement. After the close of business on the
expiration date, unexercised warrants will become void. Warrants
may be exercised as described in the applicable prospectus
supplement. When the warrant holder makes the payment and
properly completes and signs the warrant certificate at the
corporate trust office of the warrant agent or any other office
indicated in the prospectus supplement, we will, as soon as
possible, forward the debt or equity securities that the warrant
holder has purchased. If the warrant holder exercises the
warrant for less than all of the warrants represented by the
warrant certificate, we will issue a new warrant certificate for
the remaining warrants.
8
DESCRIPTION
OF DEPOSITARY SHARES
We may offer depositary shares (either separately or together
with other securities) representing fractional shares of our
preferred stock of any series. The following description sets
forth certain general terms and provisions of the depositary
shares to which any prospectus supplement may relate. The
particular terms of the depositary shares to which any
prospectus supplement may relate and the extent, if any, to
which the general provisions may apply to the depositary shares
so offered will be described in the applicable prospectus
supplement. To the extent that any particular terms of the
depositary shares, deposit agreements and depositary receipts
described in a prospectus supplement differ from any of the
terms described below, then the terms described below will be
deemed to have been superseded by that prospectus supplement. We
encourage you to read the applicable deposit agreement and
depositary receipts for additional information before you decide
whether to purchase any of our depositary shares.
In connection with the issuance of any depositary shares, we
will enter into a deposit agreement with a bank or trust
company, as depositary, which will be named in the applicable
prospectus supplement. Depositary shares will be evidenced by
depositary receipts issued pursuant to the related deposit
agreement. Immediately following our issuance of the security
related to the depositary shares, we will deposit the shares of
its preferred stock with the relevant depositary and will cause
the depositary to issue, on our behalf, the related depositary
receipts. Subject to the terms of the deposit agreement, each
owner of a depositary receipt will be entitled, in proportion to
the fraction of a share of preferred stock represented by the
related depositary share, to all the rights, preferences and
privileges of, and will be subject to all of the limitations and
restrictions on, the preferred stock represented by the
depositary receipt (including, if applicable, dividend, voting,
conversion, exchange, redemption, sinking fund, repayment at
maturity, subscription and liquidation rights).
DESCRIPTION
OF PURCHASE CONTRACTS
We may issue purchase contracts, including contracts obligating
holders to purchase from us, and for us to sell to holders, a
specific or variable number of our debt securities, shares of
common stock, preferred stock or depositary shares, warrants, or
securities of an entity unaffiliated with us, or any combination
of the above, at a future date or dates. Alternatively, the
purchase contracts may obligate us to purchase from holders, and
obligate holders to sell to us, a specific or varying number of
our debt securities, shares of common stock, preferred stock or
depositary shares, warrants, or other property, or any
combination of the above. The price of the securities or other
property subject to the purchase contracts may be fixed at the
time the purchase contracts are issued or may be determined by
reference to a specific formula described in the purchase
contracts. We may issue purchase contracts separately or as a
part of units each consisting of a purchase contract and one or
more of our other securities described in this prospectus or
securities of third parties, including U.S. Treasury
securities, securing the holders obligations under the
purchase contract. The purchase contracts may require us to make
periodic payments to holders or vice versa and the payments may
be unsecured or pre-funded on some basis. The purchase contracts
may require holders to secure the holders obligations in a
manner specified in the applicable prospectus supplement.
The applicable prospectus supplement will describe the terms of
any purchase contracts in respect of which this prospectus is
being delivered, including, to the extent applicable, the
following:
|
|
|
|
|
whether the purchase contracts obligate the holder or us to
purchase or sell, or both purchase and sell, the securities
subject to purchase under the purchase contract, and the nature
and amount of each of those securities, or the method of
determining those amounts;
|
|
|
|
whether the purchase contracts are to be prepaid or not;
|
|
|
|
whether the purchase contracts are to be settled by delivery, or
by reference or linkage to the value, performance or level of
the securities subject to purchase under the purchase contract;
|
|
|
|
any acceleration, cancellation, termination or other provisions
relating to the settlement of the purchase contracts;
|
9
|
|
|
|
|
any applicable federal income tax considerations; and
|
|
|
|
whether the purchase contracts will be issued in fully
registered or global form.
|
The preceding description sets forth certain general terms and
provisions of the purchase contracts to which any prospectus
supplement may relate. The particular terms of the purchase
contracts to which any prospectus supplement may relate and the
extent, if any, to which the general provisions may apply to the
purchase contracts so offered will be described in the
applicable prospectus supplement. To the extent that any
particular terms of the purchase contracts described in a
prospectus supplement differ from any of the terms described
above, then the terms described above will be deemed to have
been superseded by that prospectus supplement. We encourage you
to read the applicable purchase contract for additional
information before you decide whether to purchase any of our
purchase contracts.
DESCRIPTION
OF UNITS
We may issue units comprising one or more of our securities
described in this prospectus in any combination. Units may also
include debt obligations of third parties, such as
U.S. Treasury securities. Each unit will be issued so that
the holder of the unit also is the holder of each security
included in the unit. Thus, the holder of a unit will have the
rights and obligations of a holder of each included security.
The unit agreement under which a unit is issued may provide that
the securities included in the unit may not be held or
transferred separately at any time or at any time before a
specified date or occurrence.
The applicable prospectus supplement will describe the terms of
any units in respect of which this prospectus is being
delivered, including, to the extent applicable, the following:
|
|
|
|
|
the designation and terms of the units and the securities
included in the units, including whether and under what
circumstances those securities may be held or transferred
separately;
|
|
|
|
any provision for the issuance, payment, settlement, transfer or
exchange of the units or of the securities included in the units;
|
|
|
|
any applicable federal income tax considerations; and
|
|
|
|
whether the units will be issued in fully registered or global
form.
|
The preceding description sets forth certain general terms and
provisions of the units to which any prospectus supplement may
relate. The particular terms of the units to which any
prospectus supplement may relate and the extent, if any, to
which the general provisions may apply to the units so offered
will be described in the applicable prospectus supplement. To
the extent that any particular terms of the units, unit
agreements or unit certificates described in a prospectus
supplement differ from any of the terms described above, then
the terms described above will be deemed to have been superseded
by that prospectus supplement. We encourage you to read the
applicable unit agreement and unit certificate for additional
information before you decide whether to purchase any of our
units.
DESCRIPTION
OF DEBT SECURITIES
This section describes certain general terms and provisions that
we expect would be applicable to our debt securities. When we
offer to sell a particular series of debt securities, we will
describe the specific terms of that series in a supplement to
this prospectus. The following description of debt securities
will apply to the debt securities offered by this prospectus
unless we provide otherwise in the applicable prospectus
supplement. The applicable prospectus supplement for a
particular series of debt securities may specify different or
additional terms.
The debt securities offered hereby may be secured or unsecured,
and may be senior debt securities, senior subordinated debt
securities or subordinated debt securities. The debt securities
offered hereby will be issued under an indenture between us and
a trustee. The indenture will be qualified under, subject to,
and governed by, the Trust Indenture Act of 1939, as amended, or
the Trust Indenture Act.
10
General
The terms of each series of debt securities will be established
by or pursuant to a resolution of our board of directors and
detailed or determined in the manner provided in a board of
directors resolution, an officers certificate or by
a supplemental indenture. The particular terms of each series of
debt securities will be described in a prospectus supplement
relating to the series, including any pricing supplement.
We can issue an unlimited amount of debt securities under an
indenture that may be in one or more series with the same or
various maturities, at par, at a premium or at a discount. We
will set forth in a prospectus supplement, including any pricing
supplement, relating to any series of debt securities being
offered the initial offering price, the aggregate principal
amount and the following terms of the debt securities:
|
|
|
|
|
the title of the debt securities;
|
|
|
|
the price or prices (expressed as a percentage of the aggregate
principal amount) at which we will sell the debt securities;
|
|
|
|
any limit on the aggregate principal amount of the debt
securities;
|
|
|
|
the date or dates on which we will pay the principal on the debt
securities;
|
|
|
|
the rate or rates (which may be fixed or variable) per annum or
the method used to determine the rate or rates (including any
commodity, commodity index, stock exchange index or financial
index) at which the debt securities will bear interest, the date
or dates from which interest will accrue, the date or dates on
which interest will commence and be payable and any regular
record date for the interest payable on any interest payment
date;
|
|
|
|
the place or places where the principal of, premium, and
interest on the debt securities will be payable;
|
|
|
|
the terms and conditions upon which we may redeem the debt
securities;
|
|
|
|
any obligation we have to redeem or purchase the debt securities
pursuant to any sinking fund or analogous provisions or at the
option of a holder of debt securities;
|
|
|
|
the dates on which and the price or prices at which we will
repurchase the debt securities at the option of the holders of
debt securities and other detailed terms and provisions of these
repurchase obligations;
|
|
|
|
the denominations in which the debt securities will be issued,
if other than denominations of $1,000 and any integral multiple
thereof;
|
|
|
|
whether the debt securities will be issued in the form of
certificated debt securities or global debt securities;
|
|
|
|
the portion of principal amount of the debt securities payable
upon declaration of acceleration of the maturity date, if other
than the principal amount;
|
|
|
|
the currency of denomination of the debt securities;
|
|
|
|
the designation of the currency, currencies or currency units in
which payment of principal of, premium and interest on the debt
securities will be made;
|
|
|
|
if payments of principal of, premium or interest on the debt
securities will be made in one or more currencies or currency
units other than that or those in which the debt securities are
denominated, the manner in which the exchange rate with respect
to these payments will be determined;
|
|
|
|
the manner in which the amounts of payment of principal of,
premium or interest on the debt securities will be determined,
if these amounts may be determined by reference to an index
based on a currency or currencies other than that in which the
debt securities are denominated or designated to be payable or
by reference to a commodity, commodity index, stock exchange
index or financial index;
|
|
|
|
any provisions relating to any security provided for the debt
securities;
|
11
|
|
|
|
|
any addition to or change in the events of default described in
this prospectus or in the indenture with respect to the debt
securities and any change in the acceleration provisions
described in this prospectus or in the indenture with respect to
the debt securities;
|
|
|
|
any addition to or change in the covenants described in this
prospectus or in the indenture with respect to the debt
securities;
|
|
|
|
whether the debt securities will be senior or subordinated and
any applicable subordination provisions;
|
|
|
|
any other terms of the debt securities, which may modify or
delete any provision of the indenture as it applies to that
series; and
|
|
|
|
any depositaries, interest rate calculation agents, exchange
rate calculation agents or other agents with respect to the debt
securities.
|
We may issue debt securities that are exchangeable or
convertible into shares of our common stock or preferred stock.
The terms, if any, on which the debt securities may be exchanged
for or converted will be set forth in the applicable prospectus
supplement. Such terms may include provisions for conversion,
either mandatory, at the option of the holder or at our option,
in which case the number of shares of common stock or preferred
stock or other securities to be received by the holders of debt
securities would be calculated as of a time and in the manner
stated in the prospectus supplement.
We may issue debt securities that provide for an amount less
than their stated principal amount to be due and payable upon
declaration of acceleration of their maturity pursuant to the
terms of the indenture. We will provide you with information on
the federal income tax considerations and other special
considerations applicable to any of these debt securities in the
applicable prospectus supplement.
If we denominate the purchase price of any of the debt
securities in a foreign currency or currencies or a foreign
currency unit or units, or if the principal of and any premium
and interest on any series of debt securities is payable in a
foreign currency or currencies or a foreign currency unit or
units, we will provide you with information on the restrictions,
elections, general tax considerations, specific terms and other
information with respect to that issue of debt securities and
such foreign currency or currencies or foreign currency unit or
units in the applicable prospectus supplement.
Payment
of Interest and Exchange
Each debt security will be represented by either one or more
global securities registered in the name of The Depository Trust
Company, New York, New York, as Depository, or a nominee of the
Depository (we will refer to any debt security represented by a
global debt security as a book-entry debt security), or a
certificate issued in definitive registered form (we will refer
to any debt security represented by a certificated security as a
certificated debt security), as described in the applicable
prospectus supplement. Except as described under Global
Debt Securities and Book-Entry System below, book-entry
debt securities will not be issuable in certificated form.
Certificated
Debt Securities
You may transfer or exchange certificated debt securities at the
trustees office or paying agencies in accordance with the
terms of the indenture. No service charge will be made for any
transfer or exchange of certificated debt securities, but we may
require payment of a sum sufficient to cover any tax or other
governmental charge payable in connection with a transfer or
exchange.
You may transfer certificated debt securities and the right to
receive the principal of, premium and interest on certificated
debt securities only by surrendering the old certificate
representing those certificated debt securities and either we or
the trustee will reissue the old certificate to the new holder
or we or the trustee will issue a new certificate to the new
holder.
12
Global
Debt Securities and Book-Entry System
Each debt security offered by this prospectus will be issued in
the form of one or more global debt securities representing all
or part of that series of debt securities. This means that we
will not issue certificates for that series of debt securities
to the holders. Instead, a global debt security representing
that series will be deposited with, or on behalf of, the
Depository, or its successor as the Depository and registered in
the name of the Depository or a nominee of the Depository.
The Depository will keep a computerized record of its
participants (for example, your broker) whose clients have
purchased securities represented by a global debt security.
Unless it is exchanged in whole or in part for a certificated
debt security, a global debt security may not be transferred,
except that the Depository, its nominees and their successors
may transfer a global debt security as a whole to one another.
Beneficial interests in global debt securities will be shown on,
and transfers of interests will be made only through, records
maintained by the Depository and its participants. The laws of
some jurisdictions require that some purchasers take physical
delivery of securities in definitive form. These laws may impair
the ability to transfer beneficial interests in a global debt
security.
We will wire principal, interest and any premium payments to the
Depository or its nominee. We and the trustee will treat the
Depository or its nominee as the owner of the global debt
security for all purposes, including any notices and voting.
Accordingly, we, the trustee and any paying agent will have no
direct responsibility or liability to pay amounts due on a
global debt security to owners of beneficial interests in a
global debt security.
Unless we specify otherwise in the applicable prospectus
supplement, the Depository will act as depository for debt
securities issued as global debt securities. The debt securities
will be registered in the name of Cede & Co. (the
Depositorys partnership nominee).
The Depository is a limited-purpose trust company organized
under the New York Banking Law, a banking
organization within the meaning of the New York Banking
Law, a member of the Federal Reserve System, a clearing
corporation within the meaning of the New York Uniform
Commercial Code, and a clearing agency registered
pursuant to the provisions of Section 17A of the Securities
Exchange Act of 1934. The Depository holds securities that
its participants, or direct participants, deposit with the
Depository. The Depository also facilitates the post-trade
settlement among direct participants of sales and other
securities transactions in deposited securities through
electronic computerized book-entry transfers and pledges between
direct participants accounts. This eliminates the need for
physical movement of securities certificates. Direct
participants include both U.S. and
non-U.S. securities
brokers and dealers, banks, trust companies, clearing
corporations, and certain other organizations. The Depository is
a wholly-owned subsidiary of The Depository Trust &
Clearing Corporation, or DTCC. DTCC, in turn, is owned by a
number of direct participants of the Depository and Members of
the National Securities Clearing Corporation, Fixed Income
Clearing Corporation and Emerging Markets Clearing Corporation
(NSCC, FICC and EMCC, are also subsidiaries of DTCC), as well as
by the New York Stock Exchange, Inc., the American Stock
Exchange, LLC, and the National Association of Securities
Dealers, Inc. Access to the Depository system is also available
to others such as securities brokers and dealers, banks, trust
companies and clearing corporations that clear through or
maintain a custodial relationship with a direct participant,
either directly or indirectly, or indirect participants. The
rules that apply to the Depository and its direct or indirect
participants or, collectively, participants, are on file with
the SEC. More information about the Depository can be found at
www.dtcc.com.
Purchases of debt securities under the Depository system must be
made by or through direct participants, which will receive a
credit for the debt securities on the Depositorys records.
The ownership interest of each actual purchaser of each debt
security, or beneficial owner, is in turn to be recorded on the
direct and indirect participants records. Beneficial
owners will not receive written confirmation from the Depository
of their purchase. Beneficial owners are, however, expected to
receive written confirmations providing details of the
transaction, as well as periodic statements of their holdings,
from the direct or indirect participant through which the
beneficial owner entered into the transaction. Transfers of
ownership interests in the debt securities are to be
accomplished by entries made on the books of direct and indirect
participants acting on behalf of
13
beneficial owners. Beneficial owners will not receive
certificates representing their ownership interests in debt
securities, except in the event that use of the book-entry
system for the debt securities is discontinued.
To facilitate subsequent transfers, all securities deposited by
direct participants with the Depository are registered in the
name of the Depositorys partnership nominee,
Cede & Co. or such other name as may be requested by an
authorized representative of the Depository. The deposit of
securities with the Depository and their registration in the
name of Cede & Co. or such other nominee do not effect
any change in beneficial ownership. The Depository has no
knowledge of the actual beneficial owners of the debt
securities; the Depositorys records reflect only the
identity of the direct participants to whose accounts such debt
securities are credited, which may or may not be the beneficial
owners. The direct and indirect participants will remain
responsible for keeping account of their holdings on behalf of
their customers.
Conveyance of notices and other communications by the Depository
to direct participants, by direct participants to indirect
participants, and by direct participants and indirect
participants to beneficial owners will be governed by
arrangements among them, subject to any statutory or regulatory
requirements as may be in effect from time to time.
Redemption notices shall be sent to the Depository. If less than
all of the debt securities within a series are being redeemed,
the Depositorys practice is to determine by lot the amount
of the interest of each direct participant in such series to be
redeemed.
Neither the Depository nor Cede & Co. (nor such other
Depository nominee) will consent or vote with respect to the
debt securities unless authorized by a direct participant in
accordance with the Depositorys procedures. Under its
usual procedures, the Depository mails an omnibus proxy to us as
soon as possible after the record date. The omnibus proxy
assigns Cede & Co.s consenting or voting rights
to those direct participants to whose accounts the debt
securities are credited on the record date (identified in a
listing attached to the omnibus proxy).
Redemption proceeds, distributions, dividend, principal and
interest payments on the debt securities will be made to
Cede & Co., or such other nominee as may be requested
by an authorized representative of the Depository. The
Depositorys practice is to credit direct
participants accounts, upon the Depositorys receipt
of funds and corresponding detail information from us or the
trustee on payable date in accordance with their respective
holdings shown on the Depositorys records. Payments by
participants to beneficial owners will be governed by standing
instructions and customary practices, as is the case with
securities held for the accounts of customers in bearer form or
registered in street name, and will be the
responsibility of such participant and not of the Depository nor
its nominee, the trustee, or us, subject to any statutory or
regulatory requirements as may be in effect from time to time.
Payment of redemption proceeds, distributions, and dividend
payments to Cede & Co. (or such other nominee as may be
requested by an authorized representative of the Depository) is
the responsibility of us or the trustee, disbursement of such
payments to direct participants will be the responsibility of
the Depository, and disbursement of such payments to the
beneficial owners will be the responsibility of direct and
indirect participants.
The Depository may discontinue providing its services as
securities depository with respect to the debt securities at any
time by giving reasonable notice to us or the trustee. We will
issue certificated debt securities in exchange for each global
debt security if the Depository is at any time unwilling or
unable to continue as Depository or ceases to be a clearing
agency registered under the Exchange Act, and a successor
Depository registered as a clearing agency under the Exchange
Act is not appointed by us within 90 days. In addition, we
may at any time and in our sole discretion determine not to have
any of the book-entry debt securities of any series represented
by one or more global debt securities and, in that event, we
will issue certificated debt securities in exchange for the
global debt securities of that series. Global debt securities
will also be exchangeable by the holders for certificated debt
securities if an event of default with respect to the book-entry
debt securities represented by those global debt securities has
occurred and is continuing. Any certificated debt securities
issued in exchange for a global debt security will be registered
in such name or names as the Depository shall instruct the
trustee. We expect that such instructions will be based upon
directions received by the Depository from participants with
respect to ownership of book-entry debt securities relating to
such global debt security.
14
We have obtained the foregoing information in this section
concerning the Depository and the Depositorys book-entry
system from sources we believe to be reliable. We take no
responsibility for the accuracy of the information or for the
Depositorys performance of its obligations under the rules
and regulations governing its operations.
Any underwriters, dealers or agents of any debt securities may
be direct participants of the Depository.
No
Protection in the Event of a Change in Control
Unless we provide otherwise in the applicable prospectus
supplement, the debt securities will not contain any provisions
which may afford holders of the debt securities protection in
the event we have a change in control or in the event of a
highly leveraged transaction (whether or not such transaction
results in a change in control).
Covenants
Unless we provide otherwise in the applicable prospectus
supplement, the debt securities will not contain any restrictive
covenants, including covenants restricting us or any of our
subsidiaries from incurring, issuing, assuming or guarantying
any indebtedness secured by a lien on any of our or our
subsidiaries property or capital stock, or restricting us
or any of our subsidiaries from entering into any sale and
leaseback transactions.
Consolidation,
Merger and Sale of Assets
Unless we provide otherwise in the applicable prospectus
supplement, we may not consolidate with or merge into, or
convey, transfer or lease all or substantially all of our
properties and assets to, any person, or a successor person, and
we may not permit any person to merge into, or convey, transfer
or lease its properties and assets substantially as an entirety
to us, unless:
|
|
|
|
|
the successor person is a corporation, partnership, trust or
other entity organized and validly existing under the laws of
any U.S. domestic jurisdiction;
|
|
|
|
immediately after giving effect to the transaction, no event of
default shall have occurred and be continuing under the
indenture; and
|
|
|
|
certain other conditions are met.
|
Events of
Default
Unless we provide otherwise in the applicable prospectus
supplement, event of default will mean, with respect
to any series of debt securities, any of the following:
|
|
|
|
|
failure to pay principal of or any premium on any debt security
of that series when due;
|
|
|
|
failure to pay any interest on any debt security of that series
within 30 days when due;
|
|
|
|
failure to deposit any sinking fund payment within 30 days
of when due;
|
|
|
|
failure to perform any other covenant in the indenture continued
for 90 days after being given the notice required in the
indenture;
|
|
|
|
our bankruptcy, insolvency or reorganization; and
|
|
|
|
any other event of default specified in the prospectus
supplement.
|
No event of default with respect to a particular series of debt
securities (except as to certain events of bankruptcy,
insolvency or reorganization) will necessarily constitute an
event of default with respect to any other series of debt
securities. An event of default may also be an event of default
under our bank credit agreements or other debt securities in
existence from time to time and under certain guaranties by us
of any
15
subsidiary indebtedness. In addition, certain events of default
or an acceleration under the indenture may also be an event of
default under some of our other indebtedness outstanding from
time to time.
Unless we provide otherwise in the applicable prospectus
supplement, if an event of default with respect to debt
securities of any series at the time outstanding occurs and is
continuing (other than certain events of our bankruptcy,
insolvency or reorganization), then the trustee or the holders
of not less than 25% in principal amount of the outstanding debt
securities of that series may, by written notice to us (and to
the trustee if given by the holders), declare to be due and
payable immediately the principal (or, if the debt securities of
that series are discount securities, that portion of the
principal amount as may be specified in the terms of that
series) of and accrued and unpaid interest, if any, of all debt
securities of that series. In the case of an event of default
resulting from certain events of bankruptcy, insolvency or
reorganization, the principal (or such specified amount) of and
accrued and unpaid interest, if any, of all outstanding debt
securities will become and be immediately due and payable
without any declaration or other act by the trustee or any
holder of outstanding debt securities. At any time after a
declaration of acceleration with respect to debt securities of
any series has been made, but before the trustee has obtained a
judgment or decree for payment of the money due, the holders of
a majority in principal amount of the outstanding debt
securities of that series may, subject to our having paid or
deposited with the trustee a sum sufficient to pay overdue
interest and principal which has become due other than by
acceleration and certain other conditions, rescind and annul
such acceleration if all events of default, other than the
non-payment of accelerated principal and interest, if any, with
respect to debt securities of that series, have been cured or
waived as provided in the indenture. For information as to
waiver of defaults, see the discussion under the heading
Modification and Waiver below. We refer you to the
prospectus supplement relating to any series of debt securities
that are discount securities for the particular provisions
relating to acceleration of a portion of the principal amount of
the discount securities upon the occurrence of an event of
default and the continuation of an event of default.
Unless we provide otherwise in the applicable prospectus
supplement, the indenture will provide that the trustee will be
under no obligation to exercise any of its rights or powers
under the indenture at the request of any holder of outstanding
debt securities, unless the trustee receives indemnity
satisfactory to it against any loss, liability or expense.
Subject to certain rights of the trustee, the holders of a
majority in principal amount of the outstanding debt securities
of any series will have the right to direct the time, method and
place of conducting any proceeding for any remedy available to
the trustee or exercising any trust or power conferred on the
trustee with respect to the debt securities of that series.
Unless we provide otherwise in the applicable prospectus
supplement, no holder of any debt security of any series will
have any right to institute any proceeding, judicial or
otherwise, with respect to the indenture or for the appointment
of a receiver or trustee, or for any remedy under the indenture,
unless:
|
|
|
|
|
that holder has previously given to the trustee written notice
of a continuing event of default with respect to debt securities
of that series;
|
|
|
|
the holders of at least 25% in principal amount of the
outstanding debt securities of that series have made a written
request, and offered reasonable indemnity, to the trustee to
institute such proceeding as trustee; and
|
|
|
|
the trustee shall not have received from the holders of a
majority in principal amount of the outstanding debt securities
of that series a direction inconsistent with that request and
has failed to institute the proceeding within 60 days.
|
Notwithstanding the foregoing, the holder of any debt security
will have an absolute and unconditional right to receive payment
of the principal of, premium and any interest on that debt
security on or after the due dates expressed in that debt
security and to institute suit for the enforcement of payment.
We will furnish the trustee an annual statement by our officers
as to whether or not we are in default in the performance of the
indenture and, if so, specifying all known defaults.
16
Modification
and Waiver
Unless we provide otherwise in the applicable prospectus
supplement, we and the trustee may change an indenture without
the consent of any holders with respect to certain matters,
including:
|
|
|
|
|
to cure any ambiguity, defect or inconsistency;
|
|
|
|
to provide for uncertificated securities in addition to or in
place of certificated securities;
|
|
|
|
to provide for the assumption of our obligations to holders of
any debt security in the case of a merger or consolidation or
sale of all or substantially all of our assets;
|
|
|
|
to make any change that would provide any additional rights or
benefits to the holders of securities or that does not adversely
affect the legal rights under the indenture of any such holder;
|
|
|
|
to comply with requirements of the SEC in order to effect or
maintain the qualification of an indenture under the Trust
Indenture Act;
|
|
|
|
to provide for the issuance of additional securities in
accordance with the limitations set forth in the indenture as of
the date of the indenture;
|
|
|
|
to allow any guarantor to execute a supplemental indenture with
respect to debt securities and to release guarantors in
accordance with the terms of the indenture; or
|
|
|
|
to add additional obligors under the indenture and the
securities.
|
Unless we provide otherwise in the applicable prospectus
supplement, we and the trustee may modify and amend the
indenture with the consent of the holders of at least a majority
in principal amount of the outstanding debt securities of each
series affected by the modifications or amendments. We and the
trustee may not make any modification or amendment without the
consent of the holder of each affected debt security then
outstanding if that amendment will:
|
|
|
|
|
change the stated maturity of any debt security;
|
|
|
|
reduce the principal, premium, if any, or interest on any debt
security;
|
|
|
|
reduce the principal of an original issue discount security or
any other debt security payable on acceleration of maturity;
|
|
|
|
reduce the rate of interest on any debt security;
|
|
|
|
change the currency in which any debt security is payable;
|
|
|
|
impair the right to enforce any payment after the stated
maturity or redemption date;
|
|
|
|
waive any default or event of default in payment of the
principal of, premium or interest on any debt security;
|
|
|
|
waive a redemption payment or modify any of the redemption
provisions of any debt security;
|
|
|
|
adversely affect the right to convert any debt security; or
|
|
|
|
change the provisions in the indenture that relate to modifying
or amending the indenture.
|
Except for certain specified provisions, the holders of at least
a majority in principal amount of the outstanding debt
securities of any series may, on behalf of the holders of all
debt securities of that series, waive our compliance with
provisions of the indenture. The holders of a majority in
principal amount of the outstanding debt securities of any
series may, on behalf of the holders of all the debt securities
of that series, waive any past default under the indenture with
respect to that series and its consequences, except a default in
the payment of the principal of, premium or any interest on any
debt security of that series; provided, however, that the
holders of a majority in principal amount of the outstanding
debt securities of any series may rescind an acceleration and
its consequences, including any related payment default that
resulted from the acceleration.
17
Defeasance
of Debt Securities and Certain Covenants in Certain
Circumstances
Legal
Defeasance
Unless the terms of the applicable series of debt securities
provide otherwise, we may be discharged from any and all
obligations in respect of the debt securities of any series
(except for certain obligations to register the transfer or
exchange of debt securities of the series, to replace stolen,
lost or mutilated debt securities of the series, and to maintain
paying agencies and certain provisions relating to the treatment
of funds held by paying agents). We will be so discharged on the
91st day after the deposit with the trustee, in trust, of
money or U.S. government obligations or, in the case of
debt securities denominated in a single currency other than
U.S. dollars, foreign government obligations (as described
at the end of this section), that, through the payment of
interest and principal in accordance with their terms, will
provide money in an amount sufficient in the opinion of a
nationally recognized firm of independent public accountants to
pay and discharge each installment of principal, premium and
interest on and any mandatory sinking fund payments in respect
of the debt securities of that series on the stated maturity of
such payments in accordance with the terms of the indenture and
those debt securities.
This discharge may occur only if, among other things, we have
delivered to the trustee an officers certificate and an
opinion of counsel stating that we have received from, or there
has been published by, the U.S. Internal Revenue Service a
ruling or, since the date of execution of the indenture, there
has been a change in the applicable U.S. federal income tax
law, in either case to the effect that holders of the debt
securities of such series will not recognize income, gain or
loss for U.S. federal income tax purposes as a result of
the deposit, defeasance and discharge and will be subject to
U.S. federal income tax on the same amount and in the same
manner and at the same times as would have been the case if the
deposit, defeasance and discharge had not occurred.
Defeasance
of Certain Covenants
Unless the terms of the applicable series of debt securities
provide otherwise, upon compliance with certain conditions, we
may omit to comply with certain of the restrictive covenants
contained in the indenture, as well as any additional covenants
contained in a supplement to the indenture, a board resolution
or an officers certificate delivered pursuant to the
indenture. The conditions include:
|
|
|
|
|
depositing with the trustee money or U.S. government
obligations or, in the case of debt securities denominated in a
single currency other than U.S. dollars, foreign government
obligations, that, through the payment of interest and principal
in accordance with their terms, will provide money in an amount
sufficient in the opinion of a nationally recognized firm of
independent public accountants to pay principal, premium and
interest on and any mandatory sinking fund payments in respect
of the debt securities of that series on the stated maturity of
those payments in accordance with the terms of the indenture and
those debt securities;
|
|
|
|
such deposit does not result in a breach or constitute a default
under the indenture or any other agreement to which we are a
party;
|
|
|
|
no default or event of default with respect to the debt
securities shall have occurred and be continuing on the date of
deposit or during the period ending 90 days after such
date; and
|
|
|
|
delivering to the trustee an opinion of counsel to the effect
that the holders of the debt securities of that series will not
recognize income, gain or loss for U.S. federal income tax
purposes as a result of the deposit and related covenant
defeasance and will be subject to U.S. federal income tax
in the same amount and in the same manner and at the same times
as would have been the case if the deposit and related covenant
defeasance had not occurred.
|
Covenant
Defeasance and Events of Default
If we exercise our option, as described above, not to comply
with certain covenants of the indenture with respect to any
series of debt securities, and the debt securities of that
series are declared due and payable
18
because of the occurrence of any event of default, the amount of
money or U.S. government obligations or foreign government
obligations on deposit with the trustee will be sufficient to
pay amounts due on the debt securities of that series at the
time of their stated maturity but may not be sufficient to pay
amounts due on the debt securities of that series at the time of
the acceleration resulting from the event of default. However,
we will remain liable for those payments.
Foreign government obligations means, with respect
to debt securities of any series that are denominated in a
currency other than U.S. dollars:
|
|
|
|
|
direct obligations of the government that issued or caused to be
issued such currency for the payment of which obligations its
full faith and credit is pledged, which are not callable or
redeemable at the option of the issuer thereof; or
|
|
|
|
obligations of a person controlled or supervised by or acting as
an agency or instrumentality of that government, the timely
payment of which is unconditionally guaranteed as a full faith
and credit obligation by that government, which are not callable
or redeemable at the option of the issuer thereof.
|
Governing
Law
The indenture and the debt securities will be governed by, and
construed in accordance with, the laws of the State of New York,
except to the extent the Trust Indenture Act is applicable.
Regarding
the Trustee
We may appoint a separate trustee for any series of debt
securities. The trustee will have all the duties and
responsibilities of an indenture trustee specified in the Trust
Indenture Act. The trustee is not required to spend or risk its
own money or otherwise become financially liable while
performing its duties unless it reasonably believes that it will
be repaid or receive adequate indemnity.
Each indenture limits the right of the trustee, should it become
a creditor of us, to obtain payment of claims or secure its
claims.
The trustee is permitted to engage in certain other
transactions. However, if the trustee acquires any conflicting
interest, and there is default under the debt securities of any
series for which they are trustee, the trustee must eliminate
the conflict or resign.
PLAN OF
DISTRIBUTION
We may sell the securities offered by this prospectus from time
to time in one or more transactions, including without
limitation;
|
|
|
|
|
directly to purchasers;
|
|
|
|
through agents;
|
|
|
|
to or through underwriters or dealers; or
|
|
|
|
through a combination of these methods.
|
A distribution of the securities offered by this prospectus may
also be effected through the issuance of derivative securities,
including without limitation, warrants, exchangeable securities,
forward delivery contracts and the writing of options.
In addition, the manner in which we may sell some or all of the
securities covered by this prospectus includes, without
limitation, through:
|
|
|
|
|
a block trade in which a broker-dealer will attempt to sell as
agent, but may position or resell a portion of the block, as
principal, in order to facilitate the transaction;
|
|
|
|
purchases by a broker-dealer, as principal, and resale by the
broker-dealer for its account;
|
19
|
|
|
|
|
ordinary brokerage transactions and transactions in which a
broker solicits purchasers; or
|
|
|
|
privately negotiated transactions.
|
We may also enter into hedging transactions. For example, we may:
|
|
|
|
|
enter into transactions with a broker-dealer or affiliate
thereof in connection with which such broker-dealer or affiliate
will engage in short sales of the common stock pursuant to this
prospectus, in which case such broker-dealer or affiliate may
use shares of common stock received from us to close out its
short positions;
|
|
|
|
sell securities short and redeliver such shares to close out our
short positions;
|
|
|
|
enter into option or other types of transactions that require us
to deliver common stock to a broker-dealer or an affiliate
thereof, who will then resell or transfer the common stock under
this prospectus; or
|
|
|
|
loan or pledge the common stock to a broker-dealer or an
affiliate thereof, who may sell the loaned shares or, in an
event of default in the case of a pledge, sell the pledged
shares pursuant to this prospectus.
|
In addition, we may enter into derivative or hedging
transactions with third parties, or sell securities not covered
by this prospectus to third parties in privately negotiated
transactions. In connection with such a transaction, the third
parties may sell securities covered by and pursuant to this
prospectus and an applicable prospectus supplement or pricing
supplement, as the case may be. If so, the third party may use
securities borrowed from us or others to settle such sales and
may use securities received from us to close out any related
short positions. We may also loan or pledge securities covered
by this prospectus and an applicable prospectus supplement to
third parties, who may sell the loaned securities or, in an
event of default in the case of a pledge, sell the pledged
securities pursuant to this prospectus and the applicable
prospectus supplement or pricing supplement, as the case may be.
A prospectus supplement with respect to each series of
securities will state the terms of the offering of the
securities, including:
|
|
|
|
|
the terms of the offering; the name or names of any underwriters
or agents and the amounts of securities underwritten or
purchased by each of them, if any;
|
|
|
|
the public offering price or purchase price of the securities
and the net proceeds to be received by us from the sale;
|
|
|
|
any delayed delivery arrangements;
|
|
|
|
any initial public offering price;
|
|
|
|
any underwriting discounts or agency fees and other items
constituting underwriters or agents compensation;
|
|
|
|
any discounts or concessions allowed or reallowed or paid to
dealers; and
|
|
|
|
any securities exchange on which the securities may be listed.
|
The offer and sale of the securities described in this
prospectus by us, the underwriters or the third parties
described above may be effected from time to time in one or more
transactions, including privately negotiated transactions,
either:
|
|
|
|
|
at a fixed price or prices, which may be changed;
|
|
|
|
at market prices prevailing at the time of sale;
|
|
|
|
at prices related to the prevailing market prices; or
|
|
|
|
at negotiated prices.
|
20
General
Any public offering price and any discounts, commissions,
concessions or other items constituting compensation allowed or
reallowed or paid to underwriters, dealers, agents or
remarketing firms may be changed from time to time.
Underwriters, dealers, agents and remarketing firms that
participate in the distribution of the offered securities may be
underwriters as defined in the Securities Act. Any
discounts or commissions they receive from us and any profits
they receive on the resale of the offered securities may be
treated as underwriting discounts and commissions under the
Securities Act. We will identify any underwriters, agents or
dealers and describe their commissions, fees or discounts in the
applicable prospectus supplement or pricing supplement, as the
case may be.
Underwriters
and Agents
If underwriters are used in a sale, they will acquire the
offered securities for their own account. The underwriters may
resell the offered securities in one or more transactions,
including negotiated transactions. These sales may be made at a
fixed public offering price or prices, which may be changed, at
market prices prevailing at the time of the sale, at prices
related to such prevailing market price or at negotiated prices.
We may offer the securities to the public through an
underwriting syndicate or through a single underwriter. The
underwriters in any particular offering will be mentioned in the
applicable prospectus supplement or pricing supplement, as the
case may be.
Unless otherwise specified in connection with any particular
offering of securities, the obligations of the underwriters to
purchase the offered securities will be subject to certain
conditions contained in an underwriting agreement that we will
enter into with the underwriters at the time of the sale to
them. The underwriters will be obligated to purchase all of the
securities of the series offered if any of the securities are
purchased, unless otherwise specified in connection with any
particular offering of securities. Any initial public offering
price and any discounts or concessions allowed, reallowed or
paid to dealers may be changed from time to time.
We may designate agents to sell the offered securities. Unless
otherwise specified in connection with any particular offering
of securities, the agents will agree to use their best efforts
to solicit purchases for the period of their appointment. We may
also sell the offered securities to one or more remarketing
firms, acting as principals for their own accounts or as agents
for us. These firms will remarket the offered securities upon
purchasing them in accordance with a redemption or repayment
pursuant to the terms of the offered securities.
A prospectus supplement or pricing supplement, as the case may
be, will identify any remarketing firm and will describe the
terms of its agreement, if any, with us and its compensation.
In connection with offerings made through underwriters or
agents, we may enter into agreements with such underwriters or
agents pursuant to which we receive our outstanding securities
in consideration for the securities being offered to the public
for cash. In connection with these arrangements, the
underwriters or agents may also sell securities covered by this
prospectus to hedge their positions in these outstanding
securities, including in short sale transactions. If so, the
underwriters or agents may use the securities received from us
under these arrangements to close out any related open
borrowings of securities.
Dealers
We may sell the offered securities to dealers as principals. We
may negotiate and pay dealers commissions, discounts or
concessions for their services. The dealer may then resell such
securities to the public either at varying prices to be
determined by the dealer or at a fixed offering price agreed to
with us at the time of resale. Dealers engaged by us may allow
other dealers to participate in resales.
Direct
Sales
We may choose to sell the offered securities directly. In this
case, no underwriters or agents would be involved.
21
Institutional
Purchasers
We may authorize agents, dealers or underwriters to solicit
certain institutional investors to purchase offered securities
on a delayed delivery basis pursuant to delayed delivery
contracts providing for payment and delivery on a specified
future date. The applicable prospectus supplement or pricing
supplement, as the case may be will provide the details of any
such arrangement, including the offering price and commissions
payable on the solicitations.
We will enter into such delayed contracts only with
institutional purchasers that we approve. These institutions may
include commercial and savings banks, insurance companies,
pension funds, investment companies and educational and
charitable institutions.
Indemnification;
Other Relationships
We may have agreements with agents, underwriters, dealers and
remarketing firms to indemnify them against certain civil
liabilities, including liabilities under the Securities Act.
Agents, underwriters, dealers and remarketing firms, and their
affiliates, may engage in transactions with, or perform services
for, us in the ordinary course of business. This includes
commercial banking and investment banking transactions.
Market
Making, Stabilization and Other Transactions
There is currently no market for any of the offered securities
other than the common stock, which is listed on The NASDAQ
Global Market. If the offered securities are traded after their
initial issuance, they may trade at a discount from their
initial offering price, depending upon prevailing interest
rates, the market for similar securities and other factors.
While it is possible that an underwriter could inform us that it
intended to make a market in the offered securities, such
underwriter would not be obligated to do so, and any such market
making could be discontinued at any time without notice.
Therefore, no assurance can be given as to whether an active
trading market will develop for the offered securities. We have
no current plans for listing of the debt securities, rights,
preferred stock, depositary shares, warrants, purchase contracts
or units on any securities exchange or on the National
Association of Securities Dealers, Inc. automated quotation
system; any such listing with respect to any particular debt
securities, preferred stock or warrants will be described in the
applicable prospectus supplement or pricing supplement, as the
case may be.
In connection with any offering, the underwriters may purchase
and sell shares of common stock in the open market. These
transactions may include short sales, syndicate covering
transactions and stabilizing transactions. Short sales involve
syndicate sales of common stock in excess of the number of
shares to be purchased by the underwriters in the offering,
which creates a syndicate short position. Covered
short sales are sales of shares made in an amount up to the
number of shares represented by the underwriters
over-allotment option. In determining the source of shares to
close out the covered syndicate short position, the underwriters
will consider, among other things, the price of shares available
for purchase in the open market as compared to the price at
which they may purchase shares through the over-allotment
option. Transactions to close out the covered syndicate short
involve either purchases of the common stock in the open market
after the distribution has been completed or the exercise of the
over-allotment option. The underwriters may also make
naked short sales of shares in excess of the
over-allotment option. The underwriters must close out any naked
short position by purchasing shares of common stock in the open
market. A naked short position is more likely to be created if
the underwriters are concerned that there may be downward
pressure on the price of the shares in the open market after
pricing that could adversely affect investors who purchase in
the offering. Stabilizing transactions consist of bids for or
purchases of shares in the open market while the offering is in
progress for the purpose of pegging, fixing or maintaining the
price of the securities.
In connection with any offering, the underwriters may also
engage in penalty bids. Penalty bids permit the underwriters to
reclaim a selling concession from a syndicate member when the
securities originally sold by the syndicate member are purchased
in a syndicate covering transaction to cover syndicate short
positions. Stabilizing transactions, syndicate covering
transactions and penalty bids may cause the price of the
securities to be higher than it would be in the absence of the
transactions. The underwriters may, if they commence these
transactions, discontinue them at any time.
22
Any underwriters who are qualified market makers on The NASDAQ
Global Market may engage in passive market making transactions
in the securities on The NASDAQ Global Market in accordance with
Rule 103 of Regulation M. Passive market makers must
comply with applicable volume, price and other limitations of
Rule 103.
Fees and
Commissions
In compliance with the guidelines of the National Association of
Securities Dealers, Inc., or the NASD, the aggregate maximum
discount, commission or agency fees or other items constituting
underwriting compensation to be received by any NASD member or
independent broker-dealer will not exceed 8% of any offering
pursuant to this prospectus and any applicable prospectus
supplement or pricing supplement, as the case may be; however,
it is anticipated that the maximum commission or discount to be
received in any particular offering of securities will be
significantly less than this amount.
CERTAIN
LEGAL MATTERS
In connection with particular offerings of the securities in the
future, and if stated in the applicable prospectus supplements,
the validity of those securities will be passed upon for us by
Jones Day, as our counsel, and for any underwriters or agents,
by counsel named in the applicable prospectus supplement.
EXPERTS
The financial statements and managements assessment of the
effectiveness of internal control over financial reporting
(which is included in Managements Report on Internal
Control Over Financial Reporting) incorporated in this
prospectus by reference to the Annual Report on
Form 10-K
for the year ended March 31, 2006 have been so incorporated
in reliance on the report (which contains an explanatory
paragraph relating to our ability to continue as a going concern
as described in Note 1 to our financial statements and an
adverse opinion on the effectiveness of internal control over
financial reporting) of PricewaterhouseCoopers LLP, an
independent registered public accounting firm, given on the
authority of said firm as experts in auditing and accounting.
INCORPORATION
BY REFERENCE
The SEC allows us to incorporate by reference in
this prospectus the information in our documents that we file
with the SEC, which means that we disclose important information
to you by referring you to documents that we have previously
filed with the SEC or documents that we will file with the SEC
in the future. The information incorporated by reference is
considered to be part of this prospectus, and information in
documents that we file later with the SEC will automatically
update and supersede information in this prospectus. We
incorporate by reference the documents listed below into this
prospectus, and any future filings made by us with the SEC under
Section 13(a), 13(c), 14 or 15(d) of the Exchange Act until
we close this offering, including all filings made after the
date of the initial registration statement until we sell all of
the securities. We hereby incorporate by reference the following
documents:
|
|
|
|
|
our Annual Report on
Form 10-K
for the fiscal year ended March 31, 2006, filed with the
SEC on June 29, 2006 and the portions of the Proxy
Statement dated July 28, 2006, as amended, that are
incorporated by reference into the
Form 10-K;
|
|
|
|
our Quarterly Reports on
Form 10-Q
for the fiscal quarters ended June 30, 2006, filed with the
SEC on August 8, 2006, September 30, 2006, filed with
the SEC on November 9, 2006; and December 31, 2006,
filed with the SEC on February 7, 2007;
|
|
|
|
our Current Report on
Form 8-K,
filed with the SEC on April 20, 2006;
|
|
|
|
our Current Report on
Form 8-K,
filed with the SEC on June 1, 2006;
|
|
|
|
our Current Report on
Form 8-K
(excluding the information set forth in Item 2.02 and
Exhibit 99.2), filed with the SEC on June 29, 2006;
|
|
|
|
our Current Report on
Form 8-K,
filed with the SEC on July 6, 2006;
|
23
|
|
|
|
|
our Current Report on
Form 8-K,
filed with the SEC on August 4, 2006;
|
|
|
|
our Current Report on
Form 8-K,
filed with the SEC on August 8, 2006;
|
|
|
|
our Current Report on
Form 8-K,
filed with the SEC on August 23, 2006;
|
|
|
|
our Current Report on
Form 8-K/A,
filed with the SEC on August 24, 2006;
|
|
|
|
our Current Report on
Form 8-K,
filed with the SEC on August 28, 2006;
|
|
|
|
our Current Report on
Form 8-K,
filed with the SEC on September 19, 2006;
|
|
|
|
our Current Report on
Form 8-K,
filed with the SEC on September 26, 2006;
|
|
|
|
our Current Report on
Form 8-K,
filed with the SEC on October 20, 2006;
|
|
|
|
our Current Report on
Form 8-K,
filed with the SEC on November 6, 2006;
|
|
|
|
our Current Report on
Form 8-K
(excluding the information set forth in Item 2.02 and
Exhibit 99.1), filed with the SEC on November 9, 2006;
|
|
|
|
our Current Report on
Form 8-K,
filed with the SEC on November 30, 2006;
|
|
|
|
our Current Report on
Form 8-K,
filed with the SEC on December 22, 2006;
|
|
|
|
our Current Report on
Form 8-K,
filed with the SEC on January 11, 2007;
|
|
|
|
our Current Report on
Form 8-K,
filed with the SEC on January 26, 2007;
|
|
|
|
our Current Report on
Form 8-K,
filed with the SEC on March 27, 2007;
|
|
|
|
our Current Report on
Form 8-K,
filed with the SEC on March 30, 2007; and
|
|
|
|
the description of our common stock and warrants set forth in a
registration statement on
Form 8-A,
filed on May 6, 2004.
|
Any statement contained in a document incorporated or deemed to
be incorporated by reference in this prospectus is modified or
superseded for purposes of this prospectus to the extent that a
statement contained in this prospectus or in any other
subsequently filed document which also is or is deemed to be
incorporated by reference herein modifies or supersedes such
statement. Any statement so modified or superseded does not,
except as so modified or superseded, constitute a part of this
prospectus.
You may request a copy of these filings, at no cost, by written
or oral request made to us at the following address or telephone
number:
Exide Technologies
13000 Deerfield Parkway
Building 200
Alpharetta, GA 30004
(678) 566-9000
Attention: Corporate Secretary
WHERE YOU
CAN FIND ADDITIONAL INFORMATION
We file annual, quarterly and current reports, prospectus and
other information with the SEC. You may read and copy any
materials that we file with the SEC at the SECs public
reference room at 100 F Street, N.E., Washington, DC. Please
call the SEC at
1-800-SEC-0330
for more information about the operation of the public reference
rooms. The SEC also maintains an internet website, at
http://www.sec.gov, that contains our filed reports, proxy and
information statements and other information that we file
electronically with the SEC. Additionally, we make these filings
available, free of charge, on our website at
http://www.exide.com as soon as reasonably practicable after we
electronically file such materials with, or furnish them to, the
SEC. The information on our website, other than these filings,
is not, and should not be, considered part of this prospectus
and is not incorporated by reference into this document.
24
Subscription Rights to Purchase
up to 14,000,000 Shares
of Common Stock
PROSPECTUS SUPPLEMENT
August , 2007